<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001757.pub3" GROUP_ID="INCONT" ID="675499102510150692" MERGED_FROM="" MODIFIED="2013-06-25 09:27:30 +0100" MODIFIED_BY="Muhammad Imran Omar" REVIEW_NO="001" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="7.0">
<COVER_SHEET MODIFIED="2013-06-25 09:27:30 +0100" MODIFIED_BY="Muhammad Imran Omar">
<TITLE>Surgery for faecal incontinence in adults</TITLE>
<CONTACT MODIFIED="2013-06-25 09:27:30 +0100" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="65AE40EC82E26AA2011EF9F67A9A28EB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Steven</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Brown</LAST_NAME><POSITION>Consultant Surgeon</POSITION><EMAIL_1>stevebrown@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Surgery</DEPARTMENT><ORGANISATION>Sheffield Teaching Hospitals</ORGANISATION><ADDRESS_1>Dept Surgery, Northern General Hospital</ADDRESS_1><ADDRESS_2>Herried Road</ADDRESS_2><CITY>Sheffield S7</CITY><ZIP>S5 7AU</ZIP><REGION>South Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>01142715030</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-06-25 09:27:30 +0100" MODIFIED_BY="Muhammad Imran Omar"><PERSON ID="65AE40EC82E26AA2011EF9F67A9A28EB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Steven</FIRST_NAME><MIDDLE_INITIALS>R</MIDDLE_INITIALS><LAST_NAME>Brown</LAST_NAME><POSITION>Consultant Surgeon</POSITION><EMAIL_1>stevebrown@doctors.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Surgery</DEPARTMENT><ORGANISATION>Sheffield Teaching Hospitals</ORGANISATION><ADDRESS_1>Dept Surgery, Northern General Hospital</ADDRESS_1><ADDRESS_2>Herried Road</ADDRESS_2><CITY>Sheffield S7</CITY><ZIP>S5 7AU</ZIP><REGION>South Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>01142715030</PHONE_1></ADDRESS></PERSON><PERSON ID="02820351495765331156090819155227" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Himanshu</FIRST_NAME><LAST_NAME>Wadhawan</LAST_NAME><POSITION>Surgical Research Fellow</POSITION><EMAIL_1>hwadhawan@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Surgery</DEPARTMENT><ORGANISATION>Sheffield Teaching Hospitals</ORGANISATION><ADDRESS_1>Northern General Hospital</ADDRESS_1><ADDRESS_2>Herries Road</ADDRESS_2><CITY>Sheffield</CITY><ZIP>S5 7AU</ZIP><REGION>South Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="12864" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Richard</FIRST_NAME><MIDDLE_INITIALS>L</MIDDLE_INITIALS><LAST_NAME>Nelson</LAST_NAME><SUFFIX>M.D.</SUFFIX><EMAIL_1>altohorn@btinternet.com</EMAIL_1><EMAIL_2>Rick.Nelson@sth.nhs.uk</EMAIL_2><MOBILE_PHONE>07717 803 032</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of General Surgery</DEPARTMENT><ORGANISATION>Northern General Hospital</ORGANISATION><ADDRESS_1>Herries Road</ADDRESS_1><CITY>Sheffield</CITY><ZIP>S5 7AU</ZIP><REGION>Yorkshire</REGION><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+ 44 0114 271 5437</PHONE_1><FAX_1>+ 44 0114 226 6986</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-05-17 11:21:49 +0100" MODIFIED_BY="Steven Brown" NOTES="&lt;p&gt;Minor update: 26/02/03&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 19/06/06&lt;/p&gt;&lt;p&gt;Reformatted: 27/10/99&lt;/p&gt;" NOTES_MODIFIED="2013-05-17 11:21:49 +0100" NOTES_MODIFIED_BY="Steven Brown">
<UP_TO_DATE>
<DATE DAY="6" MONTH="3" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="6" MONTH="3" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="6" MONTH="3" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="9" YEAR="2010"/>
</DATES>
<WHATS_NEW MODIFIED="2013-06-06 14:11:54 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-06-06 13:50:21 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="5" YEAR="2013"/>
<DESCRIPTION>
<P>A literature search has been carried out and the text has been updated. No new trials have been added but because there is now a separate review on injectable bulking agents, this section has been removed from the review with references to this review and to the review on sacral nerve stimulation added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-06-06 13:50:25 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="5" YEAR="2013"/>
<DESCRIPTION>
<P>A literature search has been carried out and the text has been updated. No new trials have been added but because there is now a separate review on injectable bulking agents, this section has been removed from the review with references to this review and to the review on sacral nerve stimulation added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-05-17 11:20:27 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-05-17 11:20:25 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="2" MONTH="6" YEAR="2010"/>
<DESCRIPTION>
<P>New studies on injectables added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-05-17 11:20:27 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="7" YEAR="2009"/>
<DESCRIPTION>
<P>New literature search and additional relevant papers and reports added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="19" MONTH="6" YEAR="2006"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2013-06-06 14:19:11 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2013-06-06 14:19:11 +0100" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>NHS National R&amp;D Programme for People with Physical and Complex Disabilities</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Chief Scientist Office, Scottish Executive Health Department</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2013-06-06 14:19:11 +0100" MODIFIED_BY="[Empty name]">
<NAME>The National Institute for Health Research</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Incontinence Group. </P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-06-06 14:03:15 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-06-06 13:51:00 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-07-07 12:03:21 +0100" MODIFIED_BY="[Empty name]">Surgery for faecal incontinence in adults</TITLE>
<SUMMARY_BODY MODIFIED="2013-06-06 13:51:00 +0100" MODIFIED_BY="[Empty name]">
<P>Faecal incontinence (the inability to control the release of stool) can be debilitating, and is a common reason for older people to need nursing home care. It can happen for many reasons including malformations of the rectum (lower part of the intestine) or anus, neurological (nerve) diseases, or damage during childbirth or surgery. Treatments include pelvic floor muscle training, electrical stimulation, drugs and surgery. Surgery is used in selected groups of people, particularly (but not exclusively) when the defects in the muscles surrounding the anal canal can be corrected mechanically. The review found that there is still not enough evidence on which to judge whether one type of surgical operation was better or worse than another one, or better than different types of treatment for faecal incontinence. However, many of the techniques originally reviewed are now no longer in general use.<BR/>
</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-06-06 14:03:15 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2013-06-06 13:50:28 +0100" MODIFIED_BY="[Empty name]">
<P>Faecal incontinence is a debilitating problem with significant medical, social and economic implications. Treatment options include conservative, non-operative interventions (for example pelvic floor muscle training, biofeedback, drugs) and surgical procedures. A surgical procedure may be aimed at correcting an obvious mechanical defect, or augmenting a functionally deficient but structurally intact sphincter complex.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-07-07 13:39:50 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of surgical techniques for the treatment of faecal incontinence in adults who do not have rectal prolapse. Our aim was firstly to compare surgical management with non-surgical management and secondly, to compare the various surgical techniques.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-06-06 13:50:42 +0100" MODIFIED_BY="[Empty name]">
<P>Electronic searches of the Cochrane Incontinence Group Specialised Register (searched 6 March 2013), the Cochrane Colorectal Cancer Group Specialised Register (searched 6 March 2013), CENTRAL (2013, issue 1) and EMBASE (1 January 1998 to 6 March 2013) were undertaken. The British Journal of Surgery (1 January 1995 to 6 March 2013), Colorectal Diseases (1 January 2000 to 6 March 2013) and the Diseases of the Colon and Rectum (1 January 1995 to 6 March 2013) were specifically handsearched. The proceedings of the Association of Coloproctology of Great Britain and Ireland annual meetings held from 1999 to 2012 were perused. Reference lists of all relevant articles were searched for further trials.<BR/>
</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All randomised or quasi-randomised trials of surgery in the management of adult faecal incontinence (other than surgery for rectal prolapse). </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-06-06 13:50:47 +0100" MODIFIED_BY="[Empty name]">
<P>Three review authors independently selected studies from the literature, assessed the methodological quality of eligible trials and extracted data. The three primary outcome measures were change or deterioration in incontinence, failure to achieve full continence, and the presence of faecal urgency.<BR/>
</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-06-06 13:50:56 +0100" MODIFIED_BY="[Empty name]">
<P>Nine trials were included with a total sample size of 264 participants. Two trials included a group managed non-surgically. One trial compared levatorplasty with anal plug electrostimulation and one compared an artificial bowel sphincter with best supportive care. The artificial bowel sphincter resulted in significant improvements in at least one primary outcome but the numbers were small. The other trial showed no difference in the primary outcome measures.</P>
<P>Seven trials compared different surgical interventions. These included anterior levatorplasty versus postanal repair, anterior levatorplasty versus total pelvic floor repair, total pelvic floor versus postanal repair, end to end versus overlap sphincter repair, overlap repair with or without a defunctioning stoma or with or without biofeedback, and total pelvic floor repair versus repair plus internal sphincter plication and neosphincter formation versus total pelvic floor repair. Sacral nerve stimulation and injectables are considered in separate Cochrane reviews. Only one comparison had more than one trial (total pelvic floor versus postanal repair, 44 participants) and no trial showed any difference in primary outcome measures.<BR/>
</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-06-06 14:03:15 +0100" MODIFIED_BY="[Empty name]">
<P>The review is striking for the lack of high quality randomised controlled trials on faecal incontinence surgery that have been carried out in the last 10 years. Those trials that have been carried out have focused on sacral neuromodulation and injectable bulking agents, both reported in separate reviews. The continued small number of relevant trials identified together with their small sample sizes and other methodological weaknesses limit the usefulness of this review for guiding practice. It was impossible to identify or refute clinically important differences between the alternative surgical procedures. Larger rigorous trials are still needed. However, it should be recognised that the optimal treatment regime may be a complex combination of various surgical and non-surgical therapies.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-06-06 13:58:37 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-06-06 13:52:16 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2013-06-06 13:51:28 +0100" MODIFIED_BY="[Empty name]">
<P>Faecal incontinence, the inability to control the release of stool (<LINK REF="REF-Counihan-2005" TYPE="REFERENCE">Counihan 2005</LINK>), can be a debilitating problem with medical, social and economic implications. With regard to surgical intervention, three broad clinical groups of individuals can be recognised as suffering from faecal incontinence related to the anal sphincter. These are individuals with simple structural defects of the anal sphincter (for example damage sustained during childbirth), those with a weak but intact anal sphincter and those with complex disruptions of the anal sphincter (for example congenital anorectal malformations, trauma). The group with weak but intact sphincters includes different aetiologies (diabetes, neurological disorders, spinal trauma, rectal prolapse and primary muscular degeneration) (<LINK REF="REF-Kamm-1998" TYPE="REFERENCE">Kamm 1998</LINK>; <LINK REF="REF-Vaizey-1998" TYPE="REFERENCE">Vaizey 1998</LINK>).</P>
<P>The true prevalence of faecal incontinence in the community remains uncertain, with considerable variation in published data largely due to variations in case definition, but for anal incontinence (incontinence to flatus and faeces) this is thought to be approximately 2% to 17% (<LINK REF="REF-Johanson-1996" TYPE="REFERENCE">Johanson 1996</LINK>; <LINK REF="REF-Kalantar-2002" TYPE="REFERENCE">Kalantar 2002</LINK>; <LINK REF="REF-Lam-1999" TYPE="REFERENCE">Lam 1999</LINK>; <LINK REF="REF-Nakayama-1997" TYPE="REFERENCE">Nakayama 1997</LINK>; <LINK REF="REF-Nelson-1995" TYPE="REFERENCE">Nelson 1995</LINK>; <LINK REF="REF-Perry-2002" TYPE="REFERENCE">Perry 2002</LINK>; <LINK REF="REF-Siproudhis-2006" TYPE="REFERENCE">Siproudhis 2006</LINK>; <LINK REF="REF-Whitehead-2009" TYPE="REFERENCE">Whitehead 2009</LINK>). However defined, the prevalence amongst elderly individuals living in care facilities appears to be greatest. For women over 65 years and living in their own homes the estimated prevalence of faecal incontinence in the UK is 10% to 20% whilst the corresponding figure amongst men is 7% to 10%. The prevalence for both sexes rises to 25% for those living in residential homes and 40% for those living in nursing homes (<LINK REF="REF-Turnberg-1995" TYPE="REFERENCE">Turnberg 1995</LINK>). Amongst older people faecal incontinence remains a major reason for admission to nursing home care (<LINK REF="REF-Kamm-1998" TYPE="REFERENCE">Kamm 1998</LINK>). Amongst younger women, faecal incontinence may be present after 4% of vaginal deliveries (<LINK REF="REF-MacArthur-1997" TYPE="REFERENCE">MacArthur 1997</LINK>).</P>
<P>In the United States the average annual cost of treating a patient with mixed urinary and faecal incontinence in an outpatient setting was estimated at USD 17,166 (<LINK REF="REF-Mellgren-1999" TYPE="REFERENCE">Mellgren 1999</LINK>). During 1999 the direct costs of pads, appliances and other prescription items throughout hospitals and long term care settings in the UK for incontinence in general was estimated at GBP 82.5 million (<LINK REF="REF-Integrated-continence-service-2000" TYPE="REFERENCE">Integrated continence service 2000</LINK>). With the rise in numbers of elderly people in the world, this condition will be an increasing challenge to both healthcare services and home carers.</P>
</CONDITION>
<INTERVENTION MODIFIED="2013-06-06 13:51:33 +0100" MODIFIED_BY="[Empty name]">
<P>Normal continence of faeces is maintained by a series of neural reflexes (and voluntary activity) acting on specific muscle groups (<LINK REF="REF-Sun-1990" TYPE="REFERENCE">Sun 1990</LINK>; <LINK REF="REF-Uher-1998" TYPE="REFERENCE">Uher 1998</LINK>). These muscles include the smooth internal and striated external anal sphincters and the pelvic floor muscles (pubococcygeus, ileococcygeus, coccygeus and puborectalis). Control of the neural reflexes (somatic and autonomic) occurs at the level of the rectum (<LINK REF="REF-Burnstock-1990" TYPE="REFERENCE">Burnstock 1990</LINK>) and within centres in the brain stem and frontal lobes (<LINK REF="REF-Andrews-1964" TYPE="REFERENCE">Andrews 1964</LINK>). However, the precise integration of information between these centres and the interaction between both the somatic and autonomic nervous system remains to be explained (<LINK REF="REF-de-Groat-1990" TYPE="REFERENCE">de Groat 1990</LINK>).</P>
<P>A number of treatment options are currently available for faecal incontinence. These range from conservative measures aimed at symptomatic control (for example dietary manipulation, absorbent pads, anal plugs (including electrically stimulated plugs (<LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>)), and pharmacotherapy including hormonal manipulation, constipating agents, enemas, laxatives and suppositories) through to interventions aimed at correcting the underlying cause. Interventions attempting to cure the condition include both non-operative and operative techniques. Non-operative procedures include biofeedback and pelvic floor muscle training.</P>
<P>Non-operative procedures do not correct the underlying faulty continence mechanism but instead aim to reduce the symptoms and inconvenience of faecal incontinence by creating an irrigation system (for example percutaneous endoscopic colostomy, Malone antegrade colonic enema) or anal bypass (colostomy or ileostomy). Sacral nerve stimulation, in which electrodes are inserted through the sacral foramina under general anaesthetic for stimulation of the sacral nerves, is being considered in a separate Cochrane review (<LINK REF="REF-Mowatt-2007" TYPE="REFERENCE">Mowatt 2007</LINK>). Bulking agents are also considered in a separate Cochrane review (<LINK REF="REF-Maeda-2009" TYPE="REFERENCE">Maeda 2009</LINK>).</P>
<P>Operative intervention is usually carried out if appropriate assessment (including clinical history with endoanal ultrasound and physiological evaluation of the neuromuscular units) indicates the presence of a surgically correctable defect. Such surgical procedures usually involve repairing the defect. Other surgical procedures aim to augment the pelvic floor either by bulking of the sphincter, the formation of a neo-sphincter, or stimulation of the pelvic nerves (<LINK REF="REF-Pescatori-2004" TYPE="REFERENCE">Pescatori 2004</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2013-06-06 13:52:07 +0100" MODIFIED_BY="[Empty name]">
<P>The surgical interventions being evaluated are of five types.</P>
<SUBSECTION>
<HEADING LEVEL="3">I. Interventions designed to correct abnormalities of the pelvic floor</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Anterior levatorplasty</HEADING>
<P>A curved perineal incision anterior to the anal orifice is made. The levator ani muscles are identified either side of the pelvis and levatorplasty performed by placing a series of interrupted sutures through each side and tying the sutures when all have been placed. An anterior levatorplasty not only repairs any occult anterior tear, but also increases the length of the anal canal.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Postanal pelvic floor repair</HEADING>
<P>A V-shaped incision is made posterior to the anal orifice. The tissues are dissected to the internal and external sphincters, which are separated. The puborectalis muscle is separated from the rectum providing direct access to the superior aspect of the pelvic floor muscles. A series of sutures are placed in the two limbs of the pelvic floor including the puborectalis, forming a lattice across the pelvis. The theory behind the postanal repair is restoration of an acute anorectal angle, improving continence by creating a flap valve effect of the puborectalis sling.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Total pelvic floor repair</HEADING>
<P>This combines anterior levatorplasty and postanal repair.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">II. Interventions designed to correct abnormalities of the native anal sphincter</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Anterior sphincter repair</HEADING>
<P>A circumferential perineal skin or posterior fourchette incision is made and deepened through the ischiorectal fat. The ends of the sphincter muscle are identified and overlapped or apposed by a series of sutures.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Sphincter plication (external sphincter intact)</HEADING>
<P>The external sphincter muscle is dissected free. The muscle is divided or simply overlapped sufficiently to decrease the anal orifice. A series of mattress sutures are then placed to maintain the desired aperture.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">III. Interventions designed to create a new anal sphincter (neosphincter) without electrical stimulation</HEADING>
<P>This surgical option is reserved for circumstances where direct repair of the sphincter complex is considered inappropriate.</P>
<P>In one technique, skeletal muscle is imported from an adjacent site and wrapped around the anal canal creating a new sphincter (neosphincter). A number of muscles have been used including the gracilis, gluteus maximus and obturator internus.</P>
<P>Alternatively an artificial sphincter using a hydraulic silastic balloon cuff (for example Acticon or PAS) or a ring of minature magnets may be used (for example Fenix).</P>
<P>Also included in this group are the devices that attempt to tighten or bulk up the anal sphincter (for example Thiersch wires; injectable bulking materials such as silicone, collagen, autologous fat and Teflon paste; and the SECCA procedure thought to work by applying temperature-controlled radiofrequency energy to cause collagen contraction, healing and remodelling of muscle fibres (<LINK REF="REF-Takahashi-2002" TYPE="REFERENCE">Takahashi 2002</LINK>)).</P>
<P>A recent area of research that currently remains experimental is the use of progenitor cells derived from skeletal muscle myoblasts to replace or repair a damaged sphincter (<LINK REF="REF-EUCTR-2010" TYPE="REFERENCE">EUCTR 2010</LINK>; <LINK REF="REF-Michot-2012" TYPE="REFERENCE">Michot 2012</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">IV. Interventions designed to create a new anal sphincter (neosphincter) with electrical stimulation</HEADING>
<P>This is similar to the above muscle neosphincter procedure except that a nerve stimulator is implanted within the muscle wrap.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">V. Interventions designed to create antegrade colonic irrigation</HEADING>
<P>These procedures aim to produce a discrete stoma for the intermittent irrigation of the colon allowing defaecation at a convenient time and reducing incontinent episodes at inappropriate times by creating a clean colon. Techniques include the use of an appendiceal or ileal tube, or a percutaneous endoscopically or radiologically placed tube.</P>
</SUBSECTION>
</THEORY>
<IMPORTANCE MODIFIED="2013-06-06 13:52:16 +0100" MODIFIED_BY="[Empty name]">
<P>The focus of this review was to assess surgical techniques in current clinical practice for faecal incontinence. Techniques aimed at the management of faecal incontinence secondary to rectal prolapse were not included and are the subject of a separate Cochrane review by the Incontinence Group (<LINK REF="REF-Tou-2008" TYPE="REFERENCE">Tou 2008</LINK>), as are sacral nerve stimulation (<LINK REF="REF-Mowatt-2007" TYPE="REFERENCE">Mowatt 2007</LINK>) and bulking agents (injectables) (<LINK REF="REF-Maeda-2009" TYPE="REFERENCE">Maeda 2009</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-06-06 13:52:19 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the performance of surgical techniques for the treatment of faecal incontinence in adults who do not have rectal prolapse. Our aim was firstly to compare surgical techniques with non-surgical methods and secondly, to compare the various surgical techniques with each other.</P>
<P>Two main comparisons were addressed:</P>
<P>1. surgical techniques versus non-surgical methods; and</P>
<P>2. one surgical technique with another.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-06-06 13:54:08 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-06-06 13:52:52 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-06-06 13:52:20 +0100" MODIFIED_BY="[Empty name]">
<P>All randomised controlled trials of surgery in the management of faecal incontinence (other than surgery for rectal prolapse or sacral nerve stimulation).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-06-06 13:52:22 +0100" MODIFIED_BY="[Empty name]">
<P>All adults with faecal incontinence as defined by the trialists. Children were excluded as the aetiology of incontinence is more diverse and complex (for example congenital disorders).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-06-06 13:52:24 +0100" MODIFIED_BY="[Empty name]">
<P>Five types of surgical intervention have been considered.</P>
<P>I. Interventions designed to correct abnormalities of the pelvic floor.<BR/>II. Interventions designed to correct abnormalities of the native anal sphincter.<BR/>III. Interventions designed to create a new anal sphincter (neosphincter) without electrical stimulation.<BR/>IV. Interventions designed to create a new anal sphincter (neosphincter) with electrical stimulation.<BR/>V. Interventions designed to create antegrade colonic irrigation.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-06-06 13:52:52 +0100" MODIFIED_BY="[Empty name]">
<P>There is a range of perspectives from which the outcome of surgery for faecal incontinence can be viewed and this is reflected in the list of measures reported below. Nevertheless, because of the dangers of multiple statistical testing and data dependent reporting, three measures of poor outcome have been selected as primary measures. These have been presented in tabular form regardless of whether or not data were available. Data describing the other, secondary, outcomes have also been sought but were only tabulated if the data were available.<BR/>
</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-06-06 13:52:28 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>No change or deterioration in incontinence (no improvement)</LI>
<LI>Failure to achieve full continence</LI>
<LI>Presence of faecal urgency</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-06-06 13:52:52 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Patient symptoms</HEADING>
<OL>
<LI>Patient assessed measures of incontinence (patient assessment of outcome, need to wear absorbent products for incontinence, restriction in activities)</LI>
<LI>Incontinence score</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Clinical end points</HEADING>
<OL>
<LI>Post-operative complications: bleeding, post-operative infection, chronic wound pain</LI>
<LI>Adverse functional events: post-operative constipation, impaired rectal emptying</LI>
<LI>Need for additional therapy: drugs, dietary changes, repeat surgery for faecal incontinence including formation of a colostomy</LI>
<LI>Length of hospital stay</LI>
<LI>Post-operative mortality</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Physiological measures</HEADING>
<OL>
<LI>Maximum resting anal pressure</LI>
<LI>Maximum squeeze pressure</LI>
<LI>Mucosal electrosensitivity</LI>
<LI>Rectal capacity</LI>
<LI>Anal canal length</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Health status measures</HEADING>
<OL>
<LI>Condition specific health status measures (e.g. FIQL)</LI>
<LI>Psychological measures (e.g. the Hospital Anxiety and Depression Scale by <LINK REF="REF-Zigmond-1983" TYPE="REFERENCE">Zigmond 1983</LINK>)</LI>
<LI>General health measures (e.g. the Short Form-36 (SF-36) by <LINK REF="REF-Ware-1993" TYPE="REFERENCE">Ware 1993</LINK>)</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Health economics measures</HEADING>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Other outcomes</HEADING>
<P>Non-prespecified outcomes judged important when performing the review</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-06-06 13:53:44 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2013-06-06 13:53:39 +0100" MODIFIED_BY="[Empty name]">
<P>This review has drawn on the search strategy developed for the Incontinence Review Group.</P>
<P>Relevant trials were identified from the Incontinence Group Specialised Register of controlled trials, which is described under the Incontinence Group <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/INCONT/frame.html">module</A> in <I>The Cochrane Library</I>. The register contains trials identified from MEDLINE, MEDLINE in process, the Cochrane Central Register of Controlled Trials (CENTRAL) and handsearching of journals and conference proceedings. The date of the most recent search of the Register for this review was 6 March 2013. The trials in the Incontinence Group Specialised Register are also contained in CENTRAL.</P>
<P>The terms used to search the Incontinence Group Specialised Register are given below:<BR/>(TOPIC.FAECAL INCONTINENCE*)<BR/>AND<BR/>({DESIGN.CCT*} OR {DESIGN.RCT*})<BR/>AND<BR/>(INTVENT.SURG*)<BR/>(all searches were of the keyword field of Reference Manager 12, Thomson Reuters).</P>
<P>The Specialised Register of the Cochrane Colorectal Cancer Group was also searched for the previous version of the review. For this update, after contact with the Colorectal Group, the search of CENTRAL was recommended by them as it covers their Register (see below).</P>
<P>For this review the review authors also performed additional specific searches. These included systematic searches of the following electronic databases:</P>
<UL>
<LI>PubMed (1 January 1950 to 6 March 2013) using the following search terms: faecal (or fecal) incontinence (limited to randomised controlled trial);</LI>
<LI>EMBASE (on Ovid online) (1 January 1998 to 6 March 2013) using the following strategy: fecal incontinence/ OR (faecal or fecal and incontinent$).tw. These terms were combined using the Boolean operator 'OR';</LI>
<LI>CENTRAL (2013, Issue 1).</LI>
</UL>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2013-06-06 13:53:44 +0100" MODIFIED_BY="[Empty name]">
<P>The review authors also specifically searched all the reference lists of relevant articles, and handsearched the following journals and conference proceedings:</P>
<UL>
<LI>British Journal of Surgery (from January 1995 to March 2013);</LI>
<LI>Diseases of the Colon and Rectum (from January 1995 to March 2013);</LI>
<LI>Colorectal Diseases (from January 2000 to March 2013); and</LI>
<LI>conference proceedings of the Association of Coloproctology of Great Britain and Ireland annual meetings (from 1999 to 2012).</LI>
</UL>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-06-06 13:54:08 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2013-06-06 13:53:49 +0100" MODIFIED_BY="[Empty name]">
<P>Three review authors (SRB, HW, RLN) examined all the citations and abstracts derived from the electronic searches. Reports of potentially relevant trials were retrieved in full. The three review authors independently applied the selection criteria to the trials reports. Review authors were not blind to the names of authors, institutions or journals. Any disagreements were resolved by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-06-06 13:53:55 +0100" MODIFIED_BY="[Empty name]">
<P>Data extraction from the included trials was undertaken independently by the three review authors (RLN, HW, SRB). Data were processed as described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) Any difference of opinion was resolved by discussion between the review authors. Some data required extraction from figures in the publications. An attempt was made to get missing information from the trial's authors and it was obtained for one trial (<LINK REF="STD-Leroi-2005" TYPE="STUDY">Leroi 2005</LINK>). All other data were published data only.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-06-06 13:54:02 +0100" MODIFIED_BY="[Empty name]">
<P>The methodological quality of the identified trials was assessed independently by the three review authors, taking into account the quality of random allocation concealment and the description of dropouts and withdrawals as well as blinding of the patients and carers to the intervention. Any disagreements were resolved by discussion. Studies were excluded if they were not randomised or quasi-randomised controlled trials in adults. The excluded studies and the reasons for their exclusion are summarised in the table 'Characteristics of excluded studies'.</P>
</QUALITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-06-06 13:54:07 +0100" MODIFIED_BY="[Empty name]">
<P>Data were analysed using the RevMan statistical programme in Review Manager.</P>
<P>Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for dichotomous outcomes using the Mantel-Haenszel method and a fixed-effect model. Continuous variables were analysed using fixed-effect model meta-analyses of (weighted) mean differences (MDs).<BR/>
<BR/>Continuous variables were processed using the means and standard deviations. Where the results from trials had been reported in terms of the mean and standard error of the mean (SEM), then the standard deviation (SD) was calculated using the relationship defined by the equation: SD = SEM x sample size 1/2.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2013-06-06 13:54:08 +0100" MODIFIED_BY="[Empty name]">
<P>These analyses were not used as the number of trials for each type of intervention was never more than two.</P>
</SUBGROUP_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-06-06 13:57:52 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-06-06 13:55:19 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-06-06 13:54:08 +0100" MODIFIED_BY="[Empty name]">
<P>A total of 230 records were identified through the literature search and the titles and abstracts were assessed. The full text articles of 30 potentially relevant studies were obtained. Nine randomised controlled trials (RCTs) were identified and included in this review. The flow of literature through the assessment process is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-06-06 13:54:13 +0100" MODIFIED_BY="[Empty name]">
<P>Two trials compared surgical with non-surgical interventions and the remaining seven trials compared different surgical interventions or the same surgical intervention with or without an adjunct treatment. There were a total of 264 patients included in the nine trials of which only 10 were male. Six trials limited participants to those with idiopathic incontinence (no obvious structural sphincter defect) as the main cause of their symptoms (<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>; <LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>; <LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>; <LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>; <LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>; <LINK REF="STD-Yoshioka-1999" TYPE="STUDY">Yoshioka 1999</LINK>) while three trials included only those who had localised external sphincter defects (<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>; <LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>; <LINK REF="STD-Tjandra-2003" TYPE="STUDY">Tjandra 2003</LINK>).</P>
<P>Each of the nine trials was performed at a single surgical centre, five in the United Kingdom (<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>; <LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>; <LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>; <LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>; <LINK REF="STD-Yoshioka-1999" TYPE="STUDY">Yoshioka 1999</LINK>), two in Australia (<LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>; <LINK REF="STD-Tjandra-2003" TYPE="STUDY">Tjandra 2003</LINK>), one in Sweden (<LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>) and one in the Netherlands (<LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>). All had small sample sizes (range 20 to 59). Post-operative follow-up periods extended up to 47 months (<LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>). Where data were recorded from various follow-up periods, the data were analysed from the close of the study only. Further details of these nine trials are presented in the table 'Characteristics of included studies'.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-06-06 13:55:19 +0100" MODIFIED_BY="[Empty name]">
<P>Although previously included, injection of bulking agents has now been removed from this review as this intervention is covered in another review (<LINK REF="REF-Maeda-2009" TYPE="REFERENCE">Maeda 2009</LINK>). The excluded studies on bulking agents consisted of the original four trials covered in the last update (<LINK REF="STD-Maeda-2007" TYPE="STUDY">Maeda 2007</LINK>; <LINK REF="STD-Siphrouis-2004" TYPE="STUDY">Siphrouis 2004</LINK>; <LINK REF="STD-Tjandra-2004" TYPE="STUDY">Tjandra 2004</LINK>; <LINK REF="STD-Tjandra-2009" TYPE="STUDY">Tjandra 2009</LINK>) with two additional trials (<LINK REF="STD-Dehli-2013" TYPE="STUDY">Dehli 2013</LINK>; <LINK REF="STD-Graf-2011" TYPE="STUDY">Graf 2011</LINK>).</P>
<P>Eight trials were identified that compared overlap external sphincter repair with end to end repair (<LINK REF="STD-Farrell-2010" TYPE="STUDY">Farrell 2010</LINK>; <LINK REF="STD-Farrell-2012" TYPE="STUDY">Farrell 2012</LINK>; <LINK REF="STD-Fernando-2006a" TYPE="STUDY">Fernando 2006a</LINK>; <LINK REF="STD-Fitzpatrick-2000" TYPE="STUDY">Fitzpatrick 2000</LINK>; <LINK REF="STD-Garcia-V-2005" TYPE="STUDY">Garcia V 2005</LINK>; <LINK REF="STD-Nordenstam-2008" TYPE="STUDY">Nordenstam 2008</LINK>; <LINK REF="STD-Rygh-2010" TYPE="STUDY">Rygh 2010</LINK>; <LINK REF="STD-Williams-2004" TYPE="STUDY">Williams 2004</LINK>). These trials were excluded because they examined repair in the acute obstetric injury scenario. As the study participants had not necessarily reported faecal incontinence symptoms before the repair these studies did not strictly meet the criteria for inclusion. They are also covered in another Cochrane review (<LINK REF="REF-Fernando-2006b" TYPE="REFERENCE">Fernando 2006b</LINK>).</P>
<P>Four trials (<LINK REF="STD-Leroi-2005" TYPE="STUDY">Leroi 2005</LINK>; <LINK REF="STD-Michelsen-2008" TYPE="STUDY">Michelsen 2008</LINK>; <LINK REF="STD-Tjandra-2008" TYPE="STUDY">Tjandra 2008</LINK>; <LINK REF="STD-Vaizey-1999" TYPE="STUDY">Vaizey 1999</LINK>) addressed sacral nerve stimulation, which is also covered in another Cochrane review (<LINK REF="REF-Mowatt-2007" TYPE="REFERENCE">Mowatt 2007</LINK>).</P>
<P>The last study did not provide enough data to determine whether it should be included (<LINK REF="STD-Loder-1993" TYPE="STUDY">Loder 1993</LINK>). Further details of all of these trials are presented in the <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-06-06 13:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>All of the trials had methodological drawbacks, which may have resulted in significant selection, performance, attrition and detection bias.</P>
<ALLOCATION MODIFIED="2013-06-06 13:55:33 +0100" MODIFIED_BY="[Empty name]">
<P>It was unclear in three studies as to how the participants were randomised (<LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>; <LINK REF="STD-Tjandra-2003" TYPE="STUDY">Tjandra 2003</LINK>; <LINK REF="STD-Yoshioka-1999" TYPE="STUDY">Yoshioka 1999</LINK>). Randomisation was reported in four studies to have been performed by 'random numbers' (<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>; <LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>; <LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>; <LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>) and in one each by 'random blocks' (<LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>) or 'random lots' (<LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>). Even for those trials that mentioned the randomisation process, only one trial (<LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>) mentioned allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-06-06 13:55:34 +0100" MODIFIED_BY="[Empty name]">
<P>Most trials were open to performance and detection bias because of lack of blinding of the participants and investigators. In many of the trials, particularly those comparing surgical with non-surgical treatment, blinding was impossible. In one trial of sphincter repair, the participants were blinded to the intervention (<LINK REF="STD-Tjandra-2003" TYPE="STUDY">Tjandra 2003</LINK>).</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-06-06 13:56:01 +0100" MODIFIED_BY="[Empty name]">
<P>Four studies did not mention intention to treat (<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>; <LINK REF="STD-Maeda-2007" TYPE="STUDY">Maeda 2007</LINK>; <LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>; <LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>). With regard to attrition bias only three trials (<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>; <LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>; <LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>) provided information regarding withdrawals.</P>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2013-06-06 13:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>Three trials (<LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>; <LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>; <LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>) provided details regarding statistical power, minimum clinical differences sought and sample size calculation. In one of these trials (<LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>) there was data dependent stopping of the trial after recruiting 30 patients due to a measured reduction in the maximum resting anal pressure following total pelvic floor repair with internal sphincter plication. The value of data from some of the trials was further limited by the published data being presented in a form not directly usable by the review authors, such as merely expressing a statistical comparison in terms of a P value, or the use of medians and ranges rather than means plus or minus the standard deviation (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>; <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
<P>A baseline evaluation was not reported in two studies (<LINK REF="STD-Tjandra-2003" TYPE="STUDY">Tjandra 2003</LINK>; <LINK REF="STD-Yoshioka-1999" TYPE="STUDY">Yoshioka 1999</LINK>). No differences in baseline demographics or symptomatology were reported between groups in all studies except one (<LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>) where patients undergoing total pelvic floor repair were reported to have suffered incontinence symptoms for longer. The effectiveness of the surgical intervention in each trial was assessed using a variety of outcome measures.<BR/>
</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-06-06 13:57:52 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">1. Surgical versus non-surgical intervention</HEADING>
<P>We identified two trials which compared surgical with non-surgical treatment of individuals with faecal incontinence.</P>
<SUBSECTION>
<HEADING LEVEL="4">I. Interventions designed to correct abnormalities of the pelvic floor</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Levatorplasty versus anal plug electrostimulation of the pelvic floor</HEADING>
<P>(<LINK REF="STD-Osterberg--2004" TYPE="STUDY">Osterberg 2004</LINK>)</P>
<P>One primary outcome (number of patients having no change or deterioration in continence) was reported. Five of 31 patients after anterior levatorplasty and nine of 28 patients after anal plug electrostimulation did not improve (OR 0.41, 95% CI 0.12 to 1.41, <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
<P>Of the eight secondary outcomes, data suitable for analysis were unobtainable for four (incontinence score and physiology measures). For two outcomes (use of pads and complications) there were no statistically significant differences between the two groups. However, patient assessments of physical and social handicap (yes or no question) were significantly in favour of the levatorplasty (OR 0.19, 95% CI 0.06 to 0.59, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) and OR 0.05, 95% CI 0.01 to 0.29, <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>), respectively.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">II. Interventions designed to correct abnormalities of the native anal sphincter</HEADING>
<P>There were no studies comparing surgical correction of sphincter abnormality with conservative treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">III. Interventions designed to create a new anal sphincter (neosphincter) without electrical stimulation</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Artificial bowel sphincter versus supportive care</HEADING>
<P>(<LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>)</P>
<P>Although no primary outcomes were given directly it was possible to infer from the text and tables that all six patients who had a successful implant showed some improvement in continence while only one of seven patients in the control group improved (OR 0.02, 95% CI 0.0 to 0.52, <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>).</P>
<P>Secondary outcome measures included an incontinence score, incontinence specific quality of life score (Aging Males' Symptoms (AMS) QoL) and SF-36 quality of life score (mental and physical components). The incontinence score, specific quality of life score and generic mental QoL score statistically favoured the surgical intervention (MD 9.5, 95% CI 4.8 to 14.2, <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>; MD 28, 95% CI 5.7 to 50.3, <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>; and MD 7.6, 95% CI 2.70 to 12.50, <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>, respectively). The physical component of the generic quality of life score (SF-36) and the depression score were not statistically different. Complications occurred in three of the seven in the surgical group, one person requiring abandonment of the device and stoma formation (OR 11.67, 95% CI 0.48 to 282.04, <LINK REF="CMP-002.09" TYPE="ANALYSIS">Analysis 2.9</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">IV. Interventions designed to create a new anal sphincter (neosphincter) with electrical stimulation</HEADING>
<P>There were no studies comparing a stimulated neosphincter with conservative treatment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">V. Interventions designed to create an anterograde colonic irrigation system</HEADING>
<P>There were no studies comparing anterograde colonic irrigation techniques with conservative management.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Surgical versus surgical interventions</HEADING>
<P>We identified seven trials which compared different surgical approaches to the treatment of individuals with faecal incontinence. All the trials were small, and almost all the outcomes were only addressed by single trials.</P>
<SUBSECTION>
<HEADING LEVEL="4">I. Interventions designed to correct abnormalities of the pelvic floor</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">a) Anterior levatorplasty versus postanal repair</HEADING>
<P>(<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>)</P>
<P>One primary outcome measure, number of patients failing to achieve full continence, was reported. Eight of 12 patients after anterior levatorplasty and seven of 12 after postanal repair failed to achieve full continence (OR 1.41, 95% CI 0.28 to 7.09, <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
<P>Of the five secondary outcome measures reported (adverse functional effects, maximum resting anal and squeeze pressures, changes in anal canal sensation and functional anal canal length) only one (dyspareunia) was found to be statistically significantly different between the groups, in favour of postanal repair (five out of 12 versus zero out of 12; OR 11.26, 95% CI 1.64 to 77.47, <LINK REF="CMP-003.04" TYPE="ANALYSIS">Analysis 3.4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">b) Total pelvic floor repair versus anterior levatorplasty</HEADING>
<P>(<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>)</P>
<P>Only one primary outcome measure, number of patients failing to achieve full continence, was reported. Four of 12 participants after total pelvic floor repair compared to eight of 12 participants after anterior levatorplasty failed to achieve full continence (OR 0.28, 95% CI 0.06 to 1.33, <LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>).</P>
<P>Of the secondary outcome measures, five patients experienced dyspareunia after each intervention. Maximum resting anal and squeeze pressures and anal canal length remained unchanged. Ten of 10 patients after total pelvic floor repair and seven of nine patients after anterior levatorplasty failed to show an improvement in anal canal sensation after surgery.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">c) Total pelvic floor repair versus postanal repair</HEADING>
<P>(<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>; <LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>)</P>
<P>Two primary outcome measures were reported: number of patients with no change in incontinence (<LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>), and number of patients failing to achieve full continence (<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>; <LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>). In one trial (<LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>) six of 11 patients after total pelvic floor repair and six of nine patients after postanal repair showed no change in incontinence (OR 0.62, 95% CI 0.11 to 3.57, <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>). In the combined comparisons (<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>; <LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>) data from only one trial (<LINK REF="STD-Deen-1993" TYPE="STUDY">Deen 1993</LINK>) were available, with four of 12 patients after total pelvic floor repair and seven of 12 patients after postanal repair failing to achieve full continence (OR 0.38, 95% CI 0.08 to 1.84, <LINK REF="CMP-005.02" TYPE="ANALYSIS">Analysis 5.2</LINK>); whereas this applied to all 20 patients in the van Tets trial (<LINK REF="STD-van-Tets-1998" TYPE="STUDY">van Tets 1998</LINK>).</P>
<P>Of the secondary outcome measures, significantly fewer adverse functional events occurred after postanal repair (zero of 12) compared to total pelvic floor repair (five of 12) (OR 11.26, 95% CI 1.64 to 77.47, <LINK REF="CMP-005.04" TYPE="ANALYSIS">Analysis 5.4</LINK>). The functional length of the anal canal appeared to be improved after total pelvic floor repair (4.70 cm) compared with postanal repair (3.10 cm; weighted mean difference (WMD) 1.6 cm, 95% CI 0.28 to 2.92, <LINK REF="CMP-005.08" TYPE="ANALYSIS">Analysis 5.8</LINK>). For the remaining physiological measures (maximum squeeze and resting anal pressures) no differences between the groups were observed.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">II. Interventions designed to correct abnormalities of the native anal sphincter</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">a) Overlap sphincter repair versus direct end to end repair</HEADING>
<P>(<LINK REF="STD-Tjandra-2003" TYPE="STUDY">Tjandra 2003</LINK>)</P>
<P>The only study to look at overlap versus end to end repair in the non-acute (secondary repair not primary at time of rupture) setting had one primary end point. Three of 11 patients undergoing overlap repair showed no improvement in continence compared with three of the 12 patients who underwent direct repair (OR 1.13, 95% CI 0.17 to 7.24, <LINK REF="CMP-006.01" TYPE="ANALYSIS">Analysis 6.1</LINK>).</P>
<P>Of the secondary outcomes there were again no statistically significant differences for the continence and physiology scores, the use of imodium, adverse function or complications.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">b) Overlap sphincter repair versus overlap repair with defunctioning of the bowel</HEADING>
<P>(<LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>)</P>
<P>There were no primary outcome measures. Of the secondary outcome measures there were no statistical differences in continence score and physiological parameters. With regard to complications, seven of 13 patients suffered stoma-related problems but the incidence of sphincter repair-related problems was similar (OR 0.44, 95% CI 0.08 to 2.38, <LINK REF="CMP-007.07" TYPE="ANALYSIS">Analysis 7.7</LINK>). Not surprisingly the overall hospital stay was significantly greater for the stoma group due to the readmissions for stoma closure (WMD 7.8, 95% CI 4.74 to 10.86, <LINK REF="CMP-007.08" TYPE="ANALYSIS">Analysis 7.8</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">c) Overlap sphincter repair and levatorplasty versus the same repair with biofeedback</HEADING>
<P>(<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>)</P>
<P>Two primary outcomes were reported. Only one patient from each group achieved complete continence. However, patient self-evaluation suggested that only one patient of 14 from the repair and biofeedback group did not improve compared with six out of 17 from the repair only group (<LINK REF="CMP-008.01" TYPE="ANALYSIS">Analysis 8.1</LINK>).</P>
<P>Of the secondary outcomes there was no difference seen with continence, patient satisfaction or physiological scores. However, there were statistically significant differences in favour of repair with biofeedback for some of the domains of the quality of life scores: higher lifestyle score (MD 0.76, 95% CI 0.31 to 1.21, <LINK REF="CMP-008.06" TYPE="ANALYSIS">Analysis 8.6</LINK>); less depression (MD 0.75, 95% CI 0.16 to 1.34, <LINK REF="CMP-008.08" TYPE="ANALYSIS">Analysis 8.8</LINK>); and less embarrassment (MD 0.83, 95% CI 0.12 to 1.54, <LINK REF="CMP-008.09" TYPE="ANALYSIS">Analysis 8.9</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">d) Total pelvic floor repair with internal sphincter plication versus total pelvic floor repair alone</HEADING>
<P>(<LINK REF="STD-Deen-1995" TYPE="STUDY">Deen 1995</LINK>)</P>
<P>No data were available for analysis for any of the primary outcome measures.</P>
<P>A limited number of secondary outcome measures were reported. Maximum resting anal pressure showed a statistically significant difference in favour of the total pelvic floor repair alone group after surgery (MD 23.69, 95% CI 6.37 to 41.0, <LINK REF="CMP-009.05" TYPE="ANALYSIS">Analysis 9.5</LINK>). However, this was not accompanied by a significant difference in the incontinence scores between the two groups (<LINK REF="CMP-009.04" TYPE="ANALYSIS">Analysis 9.4</LINK>). Similarly, the remaining physiological outcome measures (mucosal electrosensitivity, rectal capacity and functional anal canal length) showed no significant difference between the two treatment groups. One of 15 patients after total pelvic floor repair and internal sphincter plication compared with two of 18 patients after total pelvic floor repair alone suffered post-operative complications (<LINK REF="CMP-009.09" TYPE="ANALYSIS">Analysis 9.9</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">III. Interventions designed to create a new anal sphincter (neosphincter) without electrical stimulation</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Comparison of gluteus maximus transposition (GMT), with total pelvic floor repair (TPFR)</HEADING>
<P>(<LINK REF="STD-Yoshioka-1999" TYPE="STUDY">Yoshioka 1999</LINK>)</P>
<P>Data were available for two of the primary outcome measures: number of patients failing to achieve full continence (<LINK REF="CMP-010.02" TYPE="ANALYSIS">Analysis 10.2</LINK>), and number of patients with no improvement in faecal urgency (<LINK REF="CMP-010.03" TYPE="ANALYSIS">Analysis 10.3</LINK>). There were no significant differences seen between the two groups.</P>
<P>No statistically significant differences were identified between the groups for any of the secondary outcome measures (continence score, adverse effects, mean resting anal pressure, mucosal electrosensitivity, maximum squeeze pressure and length of high pressure zone).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">IV. Interventions designed to create a new anal sphincter (neosphincter) with electrical stimulation</HEADING>
<P>There were no studies comparing formation of a new anal sphincter with electrical stimulation.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">V. Interventions designed to create an antegrade colonic irrigation system</HEADING>
<P>There were no studies comparing anterograde colonic irrigation techniques with other surgical interventions.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-06-06 13:58:19 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2013-06-06 13:58:02 +0100" MODIFIED_BY="[Empty name]">
<P>Surgical intervention has been advocated for individuals with faecal incontinence in appropriate cases since the operation of postanal repair was first popularised (<LINK REF="REF-Parks-1975" TYPE="REFERENCE">Parks 1975</LINK>). In the intervening period, improvements to surgical care and the development of new surgical options have continued to occur. However, there still appears to be no consensus on what defines optimum surgical management. Although there continues to be a few randomised controlled trials produced since the original Cochrane review, and there are some trials comparing surgery with non-surgical procedures, the results of the updated review still fail to provide robust evidence in favour of any of the alternative interventions. It should also be noted that most of the included studies are on outdated and seldom used procedures. There is very little evidence on the most commonly used procedures. However, there is weak evidence in favour of using biofeedback to supplement an operation from one small trial (<LINK REF="STD-Davis-2004" TYPE="STUDY">Davis 2004</LINK>). The use of biofeedback to improve surgical outcomes is the topic of an ongoing clinical trial from Iran (<LINK REF="REF-Ghahramani--2013" TYPE="REFERENCE">Ghahramani 2013</LINK>). Another area of ongoing research for commonly performed procedures is the use of a biological implant to reinforce sphincter repair (<LINK REF="REF-NCT01044589-2010" TYPE="REFERENCE">NCT01044589 2010</LINK>).</P>
<P>Since the last update, bulking agent injection and sacral neuromodulation are by far the main areas in this field where there is an update in the literature. Both are reported in separate reviews and therefore no longer discussed here. Certainly with regard to neuromodulation, this remains the prime area for technical advances as well as becoming the favoured surgical approach for most patients with faecal incontinence. This probably relates to the minimally invasive nature of the therapy. Ongoing trials include a comparison between bulking agents and neuromodulation for obstetric trauma (<LINK REF="REF-Norderval-2012" TYPE="REFERENCE">Norderval 2012</LINK>) and an assessment of tibial neuromodulation as an alternative to direct sacral nerve stimulation (Confident trial <LINK REF="REF-ISRCTN88559475" TYPE="REFERENCE">ISRCTN88559475</LINK>). However, there are some other techniques for future research including adaptations of the artificial sphincter (the magnetic sphincter (<LINK REF="REF-Wong-2011" TYPE="REFERENCE">Wong 2011</LINK>)) and the use of skeletal muscle cell progenitors to repair or augment sphincter function (<LINK REF="REF-EUCTR-2010" TYPE="REFERENCE">EUCTR 2010</LINK>; <LINK REF="REF-Michot-2012" TYPE="REFERENCE">Michot 2012</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2013-06-06 13:58:07 +0100" MODIFIED_BY="[Empty name]">
<P>Data reported by the trials appear to be predominantly limited to secondary outcome measures, particularly incontinence and quality of life scores and physiological parameters. Potentially relevant primary outcome measures such as the proportion of patients either failing to achieve full continence or experiencing no change or deterioration in incontinence after surgery were not reported consistently. Incontinence scores and quality of life scores were also not consistently used. Variations make comparisons difficult between studies. However, there has been a move to standardise such scores and to create validated, specific faecal incontinence assessment tools (<LINK REF="REF-Rockwood-2000" TYPE="REFERENCE">Rockwood 2000</LINK>). This may allow more meaningful comparison.</P>
<P>Physiological tests, in particular, appear to be routinely used as proxy measures of immediate effectiveness when comparing outcomes from different intervention groups. Whilst these measures may provide helpful diagnostic information their use as surrogate measures of clinical effectiveness is of concern. These measurements have been reported to be non-specific with regards to pathology, their values may overlap with those obtained from normal controls, and their results can show wide test-retest variations (<LINK REF="REF-Chen-1998" TYPE="REFERENCE">Chen 1998</LINK>; <LINK REF="REF-Felt_x002d_Bersma-1997" TYPE="REFERENCE">Felt-Bersma 1997</LINK>; <LINK REF="REF-Keating-1997" TYPE="REFERENCE">Keating 1997</LINK>; <LINK REF="REF-Parellada-1998" TYPE="REFERENCE">Parellada 1998</LINK>; <LINK REF="REF-Pfeifer-1997" TYPE="REFERENCE">Pfeifer 1997</LINK>; <LINK REF="REF-Ryhammer-1997" TYPE="REFERENCE">Ryhammer 1997</LINK>).</P>
<P>The use of endoanal ultrasound examination of patients with faecal incontinence, on which to include or exclude the presence of sphincter defects and consequently allow inclusion into some of the trials, must be interpreted cautiously. Endoanal ultrasound has limitations and identifying anterior defects is particularly difficult. These inaccuracies may result in detection bias.</P>
<P>The morbidity from some interventions was significant and needs to be taken into account when considering the effectiveness of a treatment option. In one study comparing an artifical bowel sphincter with supportive treatment nearly 50% of participants suffered peri-operative events that required additional procedures or delayed hospital discharge (<LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>). In another study investigating the need for stoma formation after anterior sphincter repair, significant complications were seen related to the stoma with no apparent difference in the continence outcomes when compared to those without a stoma (<LINK REF="STD-Hasegawa-2000" TYPE="STUDY">Hasegawa 2000</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-06-06 13:58:19 +0100" MODIFIED_BY="[Empty name]">
<P>Methodological weaknesses in many of the trials compromise the value of their results. Unfortunately a continued lack of comparisons between similar interventions allows only limited meta-analysis. This is an inherent problem with surgery for faecal incontinence where the options for treatment are numerous and the cause of the continence dysfunction in the participants is so varied. In some instances (notably <LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK> comparing an artificial sphincter with best supportive care) the statistics significantly favoured the treatment option but the numbers were small and analysis was only possible for the one study. There was one instance where there were data from more than one trial. In this comparison (total pelvic floor versus postanal repair), all the participants in both arms of one of the two trials had poor outcomes.</P>
<P>A potential drawback of studies on incontinence is the timing of assessment of outcomes. For many interventions there is deterioration with time. Sphincter repair is the classic example with many long term studies now showing deterioration, with the initial satisfaction rate of 80% at 18 months falling to below 50% after a median of 77 months (<LINK REF="REF-Malouf-2000" TYPE="REFERENCE">Malouf 2000</LINK>). Outcome data for each included study were taken from the last post-operative assessment and in only one study (<LINK REF="STD-O_x0027_Brien-2004" TYPE="STUDY">O'Brien 2004</LINK>) was this less than 12 months after the intervention.<BR/>
</P>
<P>In many of the included trials, randomisation of patients to treatment groups may have been performed using methods that were susceptible to selection bias. Adequate concealment of allocation during treatment and outcome assessment was not evident in any trial; both can potentially bias the results (<LINK REF="REF-Byar-1976" TYPE="REFERENCE">Byar 1976</LINK>). The trials described in this review included small numbers of patients and estimates of treatment differences were very imprecise. The follow-up period was generally inadequate and needs to be considerably longer for a proper evaluation of long term treatment success. For instance, non-randomised studies have reported that success rates after postanal repair dramatically decline over time and are approximately 26% at six years follow-up (<LINK REF="REF-Rainey-1990" TYPE="REFERENCE">Rainey 1990</LINK>; <LINK REF="REF-Setti-Carraro-1994" TYPE="REFERENCE">Setti Carraro 1994</LINK>). The same is true for overlap sphincter repair (<LINK REF="REF-Guttierez-2004" TYPE="REFERENCE">Guttierez 2004</LINK>; <LINK REF="REF-Halverson-2002" TYPE="REFERENCE">Halverson 2002</LINK>; <LINK REF="REF-Malouf-2000" TYPE="REFERENCE">Malouf 2000</LINK>).</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-06-06 13:58:37 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-06-06 13:58:25 +0100" MODIFIED_BY="[Empty name]">
<P>Although there are now some studies comparing surgical intervention with conservative treatment, the interventions are diverse, the outcomes remain varied, and the participant numbers are too small to provide meaningful evidence for practice. With the limited numbers of participants and the single study evidence in mind, there may be some very guarded implications for practice.<BR/>1. Routinely defunctioning the rectum by creating a stoma after sphincter repair in uncomplicated cases does not improve the outcome of the repair but does increase morbidity and hospital stay.<BR/>2. An artificial bowel sphincter may be better than conservative treatment but has significant morbidity.<BR/>3. It does not matter whether a sphincter repair is overlapped or directly apposed, the outcome is the same.</P>
<P>4. It may be that some of the outcomes of surgery can be improved by the use of supplementary biofeedback.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-06-06 13:58:37 +0100" MODIFIED_BY="[Empty name]">
<P>There is little evidence to either support or refute the efficacy of surgical interventions for faecal incontinence. Uncertainty remains on whether any surgical intervention does more good than non-surgical treatment. Further multicentre randomised controlled trials with sufficient power are required to evaluate the continuing use of the present surgical interventions for faecal incontinence related to both structural and non-structural sphincter damage. In addition, the role of physical therapies (pelvic floor muscle training and biofeedback) either as alternatives to surgical intervention or as adjuncts is required to be formally and more frequently investigated as a treatment option.</P>
<P>With careful planning many of the methodological criticisms of present trials (selection bias, blinding of outcome assessors) and problems with clinical trials in general (patient preference, recruitment difficulties, and differences in experience between centres) can be overcome by well-designed pragmatic randomised controlled trials. Individual trials must have adequate power in order to stand a good chance of detecting clinically significant differences if they exist. Only after such evaluation can patients be offered the optimum evidence based treatment for their condition and ineffective procedures identified. Researchers should carefully consider both patient and surgeon orientated outcome measures, with both inclusion and exclusion criteria which will aid generalisability of the results.</P>
<P>However, the problems with studies on faecal incontinence are not answered by improvements in the methodology alone. The issues are much more complex. For instance, a simple comparison between overlap sphincter repair and other treatments needs to take into account early success as anal sphincter repair decays rapidly (<LINK REF="REF-Guttierez-2004" TYPE="REFERENCE">Guttierez 2004</LINK>; <LINK REF="REF-Halverson-2002" TYPE="REFERENCE">Halverson 2002</LINK>; <LINK REF="REF-Malouf-2000" TYPE="REFERENCE">Malouf 2000</LINK>). Why does this occur? How long after the intervention should assessment be carried out? It certainly should be more than a year. Another example of the complexity of any therapeutic comparison is the fact that in practice treatment regimes often involve a combination of surgical and non-surgical regimes. Studies must consider which combinations work best and in what order.</P>
<P>With the multitude of both surgical and non-surgical options available for faecal incontinence a robust method of diagnosis and assessment is needed to choose the optimal therapy and this merits further development and evaluation. Most surgeons would agree that endoanal ultrasound is essential to diagnose mechanical damage to the sphincter muscle. However, the question still remains whether anal sphincter surgery is effective for incontinence if no anal sphincter defect is seen on ultrasound.</P>
<P>There are some promising trials that are ongoing and include techniques other than bulking agents and neuromodulation (see discussion). The results of these trials will hopefully be included in the next update.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-06-06 13:58:39 +0100" MODIFIED_BY="[Empty name]">
<P>This is the third update of the original Cochrane review written by Bachoo P, Brazzelli M, Grant A.<BR/>Thanks to the Cochrane Incontinence Group for their help and input into the preparation of the update.<BR/>
</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-06-06 13:58:50 +0100" MODIFIED_BY="[Empty name]">
<P>One review author (P Bachoo) wrote the initial protocol of the review. Two review authors (P Bachoo, M Brazzelli) assessed the pertinence and quality of included studies and independently extracted data from trials reports. All review authors (P Bachoo, M Brazzelli, A Grant) interpreted the results and contributed to the writing of the initial version of the review.<BR/>With regard to the updates, three review authors (SR Brown, H Wadhawan, R Nelson) assessed the appropriateness and quality of the further studies, interpreted the results and contributed to the final version of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-06-06 14:11:16 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-06-06 14:11:16 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-06-06 14:02:46 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Davis-2004" MODIFIED="2010-07-07 13:25:51 +0100" MODIFIED_BY="[Empty name]" NAME="Davis 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-07-07 13:25:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davis KJ, Kumar D, Poloniecki J</AU>
<TI>Adjuvant biofeedback following anal sphincter repair: a randomized study</TI>
<SO>Alimentary Pharmacology &amp; Therapy</SO>
<YR>2004</YR>
<VL>20</VL>
<PG>539-49</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deen-1993" MODIFIED="2010-07-07 11:09:36 +0100" MODIFIED_BY="[Empty name]" NAME="Deen 1993" YEAR="1993">
<REFERENCE MODIFIED="2010-07-07 11:09:36 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Deen KI, Oya M, Oritz J, Keighley MRB. Randomized trial comparing three forms of pelvic floor repair for neuropathic faecal incontinence. Br J Surg 1993; 80: 794-798.&lt;/p&gt;&lt;p&gt;Oya M, Oritz J, Grant EA, Chattopadhyay G, Asper J, Keighley MRB. A video proctographic assessment of the changes in pelvic floor function following three forms of repair for post-obstetric neuropathic faecal incontinence. Dig Surg 1984;11:20-24.&lt;/p&gt;" NOTES_MODIFIED="2010-07-07 11:09:36 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deen KI, Oya M, Oritz J, Keighley MRB</AU>
<TI>Randomized trial comparing three forms of pelvic floor repair for neuropathic faecal incontinence</TI>
<SO>British Journal of Surgery</SO>
<YR>1993</YR>
<VL>80</VL>
<PG>794-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deen-1995" MODIFIED="2009-09-06 23:56:53 +0100" MODIFIED_BY="[Empty name]" NAME="Deen 1995" YEAR="1995">
<REFERENCE MODIFIED="2009-09-06 23:56:53 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Deen KI, Kumar D, Williams JG, Grant EA, Keighley MRB. Randomized trial of internal anal sphincter plication with pelvic floor repair for neuropathic fecal incontinence. Dis Colon Rectum 1995; 38(1): 14-18.&lt;/p&gt;" NOTES_MODIFIED="2009-09-06 23:56:53 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deen KI, Kumar D, Williams JG, Grant EA, Keighley MRB</AU>
<TI>Randomized trial of internal anal sphincter plication with pelvic floor repair for neuropathic fecal incontinence</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1995</YR>
<VL>38</VL>
<NO>1</NO>
<PG>14-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hasegawa-2000" MODIFIED="2013-06-06 14:02:38 +0100" MODIFIED_BY="[Empty name]" NAME="Hasegawa 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-06-06 14:02:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasegawa H, Yoshioka K, Keighley MRB</AU>
<TI>Randomized trial of fecal diversion for sphincter repair</TI>
<SO>Disease of the Colon and Rectum</SO>
<YR>2000</YR>
<VL>43</VL>
<PG>961-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Brien-2004" MODIFIED="2013-06-06 14:02:46 +0100" MODIFIED_BY="[Empty name]" NAME="O'Brien 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-06 14:02:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Brien PE, Dixon JB, Skinner S, Laurie C, Khera A, Fonda D</AU>
<TI>A prospective randomized controlled clinical trial of placement of the artificial bowel sphincter (Acticon neosphincter) for the control of fecal incontinence</TI>
<SO>Disease of the Colon and Rectum</SO>
<YR>2004</YR>
<VL>47</VL>
<PG>1852-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Osterberg--2004" MODIFIED="2009-11-11 10:02:17 +0000" MODIFIED_BY="[Empty name]" NAME="Osterberg  2004" YEAR="2004">
<REFERENCE MODIFIED="2009-11-11 10:02:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Osterberg A, Edebol Eeg-Olofsson K, Hallden M, Graf W</AU>
<TI>Randomized clinical trial comparing conservative and surgical treatment of neurogenic faecal incontinence</TI>
<SO>British Journal of Surgery</SO>
<YR>2004</YR>
<VL>91</VL>
<PG>1131-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tjandra-2003" MODIFIED="2010-07-07 13:28:32 +0100" MODIFIED_BY="[Empty name]" NAME="Tjandra 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-07-07 13:28:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tjandra JJ, Han WR, Goh J, Carey M, Dwyer P</AU>
<TI>Direct repair versus overlapping sphincter repair. A randomised controlled trial</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2003</YR>
<VL>46</VL>
<PG>937-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-Tets-1998" NAME="van Tets 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;van Tets WF, Kuijpers JHC. Pelvic floor procedures produce no consistent changes in anatomy or physiology. Dis colon rectum 1998; 41(3):365-369.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van Tets WF, Kuijpers JHC</AU>
<TI>Pelvic floor procedures produce no consistent changes in anatomy or physiology</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1998</YR>
<VL>41</VL>
<NO>3</NO>
<PG>365-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yoshioka-1999" MODIFIED="2009-11-09 01:28:49 +0000" MODIFIED_BY="[Empty name]" NAME="Yoshioka 1999" YEAR="1999">
<REFERENCE MODIFIED="2009-11-09 01:28:49 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Yoshioka K, Ogunbiyi OA, Keighley MRB. Pilot study of total pelvic floor repair or Gluteus Maximus transpostion for postopbstetric neuropathic fecal incontinence. Dis colon rectum 1999; 42(2): 252257.&lt;/p&gt;" NOTES_MODIFIED="2009-11-09 01:28:49 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yoshioka K, Ogunbiyi OA, Keighley MRB</AU>
<TI>Pilot study of total pelvic floor repair or Gluteus Maximus transposition for postobstetric neuropathic fecal incontinence</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1999</YR>
<VL>42</VL>
<NO>2</NO>
<PG>252-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-06-06 14:11:16 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Dehli-2013" MODIFIED="2013-05-16 16:55:24 +0100" MODIFIED_BY="[Empty name]" NAME="Dehli 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-05-16 16:55:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Delhi T, Stordahl A, Vatten LJ, Romundstad PR, Mevik K, Sahlin Y, et al</AU>
<TI>Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomised controlled trial</TI>
<SO>Scandinavian Journal of Gastroenterology</SO>
<YR>2013</YR>
<VL>48</VL>
<NO>3</NO>
<PG>302-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farrell-2010" MODIFIED="2013-06-06 14:11:16 +0100" MODIFIED_BY="[Empty name]" NAME="Farrell 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-06 14:11:16 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farrell SA, Gilmour D, Turnbull GK, Schmidt MH, Baskett TF, Flowerdew G, Fanning CA</AU>
<TI>Overlapping compared with end-to-end repair of third- and fourth-degree obstetric anal sphincter tears: a randomised controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2010</YR>
<VL>116</VL>
<NO>1</NO>
<PG>16-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Farrell-2012" MODIFIED="2013-06-06 14:11:09 +0100" MODIFIED_BY="[Empty name]" NAME="Farrell 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-06-06 14:11:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Farrell SA, Flowerdew G, Gilmour D, Turnbull GK, Schmidt MH, Baskett TF, Fanning CA</AU>
<TI>Overlapping compared with end-to-end repair of complete third-degree or fourth-degree obstetric tears: three-year follow up of a randomised controlled trial.</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2012</YR>
<VL>120</VL>
<NO>4</NO>
<PG>803-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fernando-2006a" MODIFIED="2013-06-06 14:11:03 +0100" MODIFIED_BY="[Empty name]" NAME="Fernando 2006a" YEAR="2006">
<REFERENCE MODIFIED="2013-06-06 14:11:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fernando R, Sultan AH, Kettle C, Radley S, Jones P, O'Brien S</AU>
<TI>A randomised trial of overlap vs end-to-end primary repair of the anal sphincter (abstract)</TI>
<SO>Neurourology and Urodynamics</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>5/6</NO>
<PG>411-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-06 14:10:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fernando RJ, Sultan AH, Kettle C, Radley S, Jones P, O'Brien PM</AU>
<TI>Repair techniques for obstetric anal sphincter injuries: a randomized controlled trial</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>2006</YR>
<VL>107</VL>
<NO>6</NO>
<PG>1261-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fitzpatrick-2000" MODIFIED="2013-06-06 14:10:48 +0100" MODIFIED_BY="[Empty name]" NAME="Fitzpatrick 2000" YEAR="2000">
<REFERENCE MODIFIED="2013-06-06 14:10:48 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Fitzpatrick M, Behan M, O'Connell R, O'Herlihy C</AU>
<TI>A randomised clinical trial comparing primary overlap with approximation repair of third-degree tears</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2000</YR>
<VL>183</VL>
<PG>1220-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-06-06 14:10:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fitzpatrick M, Cassidy M, Behan M, O'Herlihy C, O'Connell PR</AU>
<TI>Primary anal sphincter repair: influence of technique of repair (abstract)</TI>
<SO>Colorectal Disease</SO>
<YR>1999</YR>
<VL>1 Suppl 1</VL>
<PG>10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garcia-V-2005" MODIFIED="2013-06-06 14:10:34 +0100" MODIFIED_BY="[Empty name]" NAME="Garcia V 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-06 14:10:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garcia V, Rogers RG, Kim SS, Hall RJ, Kammerer-Doak DN</AU>
<TI>Primary repair of obstetric anal sphincter laceration: A randomised trial of two surgical techniques</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2005</YR>
<VL>192</VL>
<PG>1697-701</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Graf-2011" MODIFIED="2013-01-29 12:08:07 +0000" MODIFIED_BY="[Empty name]" NAME="Graf 2011" YEAR="2011">
<REFERENCE MODIFIED="2013-01-29 12:08:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M, NASHA Dx Study Group</AU>
<TI>Efficacy of dextranomer in stabilised hyaluronic acid for the treatment of faecal incontinence: a randomised, sham-controlled trial</TI>
<SO>Lancet</SO>
<YR>2011</YR>
<VL>377</VL>
<NO>9770</NO>
<PG>997-1003</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leroi-2005" MODIFIED="2013-06-06 14:10:27 +0100" MODIFIED_BY="[Empty name]" NAME="Leroi 2005" YEAR="2005">
<REFERENCE MODIFIED="2013-06-06 14:10:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leroi AM, Parc Y, Lehur PA, Mion F, Barth X, Rullier E, et al</AU>
<TI>Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study</TI>
<SO>Annals of Surgery</SO>
<YR>2005</YR>
<VL>242</VL>
<NO>5</NO>
<PG>662-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="16244539"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Loder-1993" MODIFIED="2009-11-11 10:06:40 +0000" MODIFIED_BY="[Empty name]" NAME="Loder 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-11-11 10:06:40 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Letter/comment&lt;/p&gt;" NOTES_MODIFIED="2009-11-11 10:06:40 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Loder PB, Phillips RK</AU>
<TI>Randomized trial comparing three forms of pelvic floor repair for neuropathic faecal incontinence</TI>
<SO>British Journal of Surgery</SO>
<YR>1993</YR>
<VL>80</VL>
<NO>10</NO>
<PG>1352</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maeda-2007" MODIFIED="2013-06-06 14:10:21 +0100" MODIFIED_BY="[Empty name]" NAME="Maeda 2007" YEAR="2007">
<REFERENCE MODIFIED="2013-06-06 14:10:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maeda Y, Vaisey CJ, Kamm MA</AU>
<TI>Pilot study of two new injectable bulking agents for the treatment of faecal incontinence</TI>
<SO>Colorectal Disease</SO>
<YR>2007</YR>
<VL>10</VL>
<NO>3</NO>
<PG>268-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Michelsen-2008" MODIFIED="2013-06-06 14:10:13 +0100" MODIFIED_BY="[Empty name]" NAME="Michelsen 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-06 14:10:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Michelsen HB, Krogh K, Buntzen S, Laurberg S</AU>
<TI>A prospective randomised study: switch off the sacral nerve stimulator during the night?</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2008</YR>
<VL>51</VL>
<NO>5</NO>
<PG>538-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nordenstam-2008" MODIFIED="2013-06-06 08:02:15 +0100" MODIFIED_BY="[Empty name]" NAME="Nordenstam 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-06 08:02:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nordenstam J, Mellgren A, Altman D, López A, Johansson C, Anzén B, et al</AU>
<TI>Immediate or delayed repair of obstetric anal sphincter tears - a randomised controlled trial</TI>
<SO>BJOG</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>7</NO>
<PG>857-65</PG>
<IDENTIFIERS MODIFIED="2010-07-07 13:34:24 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2010-07-07 13:30:46 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rygh-2010" MODIFIED="2013-06-06 14:09:57 +0100" MODIFIED_BY="[Empty name]" NAME="Rygh 2010" YEAR="2010">
<REFERENCE MODIFIED="2013-06-06 14:09:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rygh AB, Korner H</AU>
<TI>The overlap technique versus end-to-end approximation technique for primary repair of obstetric anal sphincter rupture: a randomised controlled study</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2010</YR>
<VL>89</VL>
<NO>10</NO>
<PG>1256-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siphrouis-2004" MODIFIED="2013-06-06 14:10:04 +0100" MODIFIED_BY="[Empty name]" NAME="Siphrouis 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-06 14:10:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siproudhis L, Morcet J, Laine F</AU>
<TI>Elastomer implants in faecal incontinence: a blind, randomised placebo-controlled study</TI>
<SO>Alimentary Pharmacology and Therapeutics</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>9</NO>
<PG>1125-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tjandra-2004" MODIFIED="2013-06-06 14:09:50 +0100" MODIFIED_BY="[Empty name]" NAME="Tjandra 2004" YEAR="2004">
<REFERENCE MODIFIED="2013-06-06 14:09:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tjandra JJ, Lim JF, Hiscock R, Rajendra P</AU>
<TI>Injectable silicone biomaterial for faecal incontinence caused by internal anal sphincter dysfunction is effective</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2004</YR>
<VL>47</VL>
<NO>12</NO>
<PG>2138-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tjandra-2008" MODIFIED="2013-06-06 14:09:43 +0100" MODIFIED_BY="[Empty name]" NAME="Tjandra 2008" YEAR="2008">
<REFERENCE MODIFIED="2013-06-06 14:09:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tjandra JJ, Chan MK, Yeh CH, Murray-Green C</AU>
<TI>Sacral nerve stimulation is more effective than optimal medical therapy for severe faecal incontinence: a randomised controlled trial</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2008</YR>
<VL>51</VL>
<NO>5</NO>
<PG>494-502</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tjandra-2009" MODIFIED="2013-06-06 14:09:37 +0100" MODIFIED_BY="[Empty name]" NAME="Tjandra 2009" YEAR="2009">
<REFERENCE MODIFIED="2013-06-06 14:09:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tjandra JJ, Chan MK, Yeh HC</AU>
<TI>Injectable silicone biomaterial (PTQ) is more effective than carbon-coated beads (Durasphere) in treating passive faecal incontinence - a randomized controlled trial</TI>
<SO>Colorectal Disease</SO>
<YR>2009</YR>
<VL>11</VL>
<NO>4</NO>
<PG>382-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vaizey-1999" MODIFIED="2013-06-06 14:09:31 +0100" MODIFIED_BY="[Empty name]" NAME="Vaizey 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-06-06 14:09:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vaizey CJ, Kamm MA, Roy AJ, Nicholls RJ</AU>
<TI>Double blind crossover study of sacral nerve stimulation for fecal incontinence</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1999</YR>
<VL>43</VL>
<PG>298-302</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Williams-2004" MODIFIED="2010-07-07 13:30:08 +0100" MODIFIED_BY="[Empty name]" NAME="Williams 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-07-07 13:30:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Williams A, Adams E, Tincello D, Alfirevic Z, Richmond D</AU>
<TI>Randomised controlled trial of third degree perineal tear: medium term outcome (abstract)</TI>
<SO>Proceedings of the International Continence Society UK 11th annual scientific meeting</SO>
<YR>2004</YR>
<PG>33-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="17174"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-06-06 14:09:19 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2013-06-06 14:09:19 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Andrews-1964" NAME="Andrews 1964" NOTES="&lt;p&gt;Andrews J, Nathan P. Lesions of the anterior frontal lobes and disturbances of micturition and defecation. Brain 1964; 87: 233-62.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Andrews J, Nathan P</AU>
<TI>Lesions of the anterior frontal lobes and disturbances of micturition and defecation</TI>
<SO>Brain</SO>
<YR>1964</YR>
<VL>87</VL>
<PG>233-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Burnstock-1990" NAME="Burnstock 1990" TYPE="JOURNAL_ARTICLE">
<AU>Burnstock G</AU>
<TI>Innervation of bladder and bowel</TI>
<SO>Ciba Foundation Symposium</SO>
<YR>1990</YR>
<VL>151</VL>
<PG>2-18, 18-26</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Byar-1976" MODIFIED="2013-06-06 14:09:19 +0100" MODIFIED_BY="[Empty name]" NAME="Byar 1976" NOTES="&lt;p&gt;Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH. Randomized clinical trials. Perspectives on some recent ideas. New Eng J medicine 1976, 295(2): 74-80.&lt;/p&gt;" NOTES_MODIFIED="2013-06-06 14:09:19 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, et al</AU>
<TI>Randomized clinical trials. Perspectives on some recent ideas</TI>
<SO>New England Journal of Medicine</SO>
<YR>1976</YR>
<VL>295</VL>
<NO>2</NO>
<PG>74-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chen-1998" NAME="Chen 1998" NOTES="&lt;p&gt;Chen ASH, Luchtefeld MA, Senagore AJ, Mackeigan JM, Hoyt C. Pudendal nerve latency. Does it predict outcome of anal sphincter repair. Dis Colon and Rectum 1998; 41(8): 1005-9.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Chen ASH, Luchtefeld MA, Senagore AJ, Mackeigan JM, Hoyt C</AU>
<TI>Pudendal nerve latency. Does it predict outcome of anal sphincter repair</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1998</YR>
<VL>41</VL>
<NO>8</NO>
<PG>1005-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Counihan-2005" MODIFIED="2010-07-07 13:23:32 +0100" MODIFIED_BY="[Empty name]" NAME="Counihan 2005" TYPE="BOOK_SECTION">
<AU>Counihan TC, Madoff RD</AU>
<TI>Faecal incontinence</TI>
<SO>Current therapy in Colon and Rectal Surgery</SO>
<YR>2005</YR>
<PG>105-12</PG>
<EN>2nd</EN>
<ED>Fazio VW, Church JM, Delaney CP</ED>
<PB>Elsevier Mosby</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-de-Groat-1990" NAME="de Groat 1990" TYPE="JOURNAL_ARTICLE">
<AU>de Groat WC</AU>
<TI>Central neural control of the lower urinary tract</TI>
<SO>Ciba Foundation Symposium</SO>
<YR>1990</YR>
<VL>151</VL>
<PG>27-44, 44-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-EUCTR-2010" MODIFIED="2013-06-06 08:08:37 +0100" MODIFIED_BY="[Empty name]" NAME="EUCTR 2010" TYPE="UNPUBLISHED">
<AU>Anonymous</AU>
<TI>Skeletal muscle-derived cell implantation for the treatment of fecal incontinence: a multicentre, randomized, double-blind, placebo controlled, parallel, dose-finding clinical study
</TI>
<SO>EU Clinical Trials Register</SO>
<YR>2011</YR>
<IDENTIFIERS MODIFIED="2013-05-16 16:32:45 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-05-16 16:32:45 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="EUCTR2010-021463-32-AT"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Felt_x002d_Bersma-1997" MODIFIED="2013-06-06 08:08:49 +0100" MODIFIED_BY="[Empty name]" NAME="Felt-Bersma 1997" NOTES="&lt;p&gt;Felt -Bersma RJF, Poen AC, Cuesta MA, Meuwissen SGM. Anal sensitivity test; what does it measure and do we need it. Cause or derivative of anorectal complaints. Dis Colon Rectum 1997; 40(7): 811-6.&lt;/p&gt;" NOTES_MODIFIED="2013-06-06 08:08:49 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Felt-Bersma RJF, Poen AC, Cuesta MA, Meuwissen SGM</AU>
<TI>Anal sensitivity test; what does it measure and do we need it. Cause or derivative of anorectal complaints</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1997</YR>
<VL>40</VL>
<NO>7</NO>
<PG>811-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fernando-2006b" MODIFIED="2013-05-16 16:28:24 +0100" MODIFIED_BY="[Empty name]" NAME="Fernando 2006b" TYPE="COCHRANE_REVIEW">
<AU>Fernando RJ, Sultan AHH, Kettle C, Thakar R, Radley S</AU>
<TI>Methods of repair for obstetric anal sphincter injury</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<PG>CD002866</PG>
<IDENTIFIERS MODIFIED="2013-05-16 16:28:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-05-16 16:28:24 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002866.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Ghahramani--2013" MODIFIED="2013-06-06 14:09:02 +0100" MODIFIED_BY="[Empty name]" NAME="Ghahramani  2013" TYPE="UNPUBLISHED">
<AU>Ghahramani</AU>
<TI>Evaluation of efficacy of preoperative biofeedback therapy before sphincteroplasty - levatorplasty for fecal incontinence management due to obstetric trauma</TI>
<SO>Iranian Registry of Clinical Trials</SO>
<YR>2013</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guttierez-2004" MODIFIED="2013-06-06 14:08:55 +0100" MODIFIED_BY="[Empty name]" NAME="Guttierez 2004" TYPE="JOURNAL_ARTICLE">
<AU>Guttierez AB, Madoff RD, Lowry AC, Parker SC, Buie WD, Baxter NN</AU>
<TI>Long-term results of anterior sphincteroplasty</TI>
<SO>Disease of the Colon and Rectum</SO>
<YR>2004</YR>
<VL>47</VL>
<PG>727-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Halverson-2002" MODIFIED="2010-07-07 13:33:51 +0100" MODIFIED_BY="[Empty name]" NAME="Halverson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Halverson AJ, Hull TL</AU>
<TI>Long-term outcome of overlapping anal sphincter repair</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2002</YR>
<VL>45</VL>
<PG>345-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2013-06-06 14:08:26 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="BOOK_SECTION">
<AU>Higgins JPT, Green S</AU>
<TO>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008].</TO>
<SO>The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org</SO>
<YR>2008</YR>
<ED>Higgins JPT, Green S</ED>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Integrated-continence-service-2000" MODIFIED="2010-07-07 13:35:00 +0100" MODIFIED_BY="[Empty name]" NAME="Integrated continence service 2000" TYPE="OTHER">
<AU>Bladder and Bowel Foundation</AU>
<TI>Making the case for an integrated continence service</TI>
<SO>Bladder and Bowel Foundation</SO>
<YR>2000</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ISRCTN88559475" MODIFIED="2013-06-06 14:08:46 +0100" MODIFIED_BY="[Empty name]" NAME="ISRCTN88559475" TYPE="UNPUBLISHED">
<AU>Horrocks E, Knowles C</AU>
<TI>Control of faecal incontinence using distal neuromodulation</TI>
<SO>ISRCTN Register</SO>
<YR>2011</YR>
<IDENTIFIERS MODIFIED="2013-03-31 11:23:16 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-03-31 11:23:16 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="ISRCTN8855975"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Johanson-1996" MODIFIED="2009-11-08 19:42:51 +0000" MODIFIED_BY="[Empty name]" NAME="Johanson 1996" NOTES="&lt;p&gt;Johanson JF, Lafferty J. Epidemiology of faecal incontinence: the silent affliction. Am J Gastrenerol; 1996; 91(1): 33-36.&lt;/p&gt;" NOTES_MODIFIED="2009-11-08 19:42:51 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Johanson JF, Lafferty J</AU>
<TI>Epidemiology of faecal incontinence: the silent affliction</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>1996</YR>
<VL>91</VL>
<NO>1</NO>
<PG>33-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kalantar-2002" MODIFIED="2013-06-06 14:08:04 +0100" MODIFIED_BY="[Empty name]" NAME="Kalantar 2002" TYPE="JOURNAL_ARTICLE">
<AU>Kalantar JS, Howell S, Talley NJ</AU>
<TI>Prevalence of faecal incontinence and associated risk factors; an under-diagnosed problem in the Australian community?</TI>
<SO>Medical Journal of Australia</SO>
<YR>2002</YR>
<VL>176</VL>
<PG>54-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kamm-1998" NAME="Kamm 1998" NOTES="&lt;p&gt;Kamm M.A. Fortnightly review Faecal incontinence. BMJ 1998; 316(7130): 528-32.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Kamm MA</AU>
<TI>Faecal incontinence</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>316</VL>
<NO>7130</NO>
<PG>528-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keating-1997" NAME="Keating 1997" NOTES="&lt;p&gt;Keating JP, Stewart PJ, Eyers AA, Warner D, Bokey EL. Are special investigations of value in the management of patients with fecal incontinence. Dis Colon Rectum 1997; 40(8): 896-901.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Keating JP, Stewart PJ, Eyers AA, Warner D, Bokey EL</AU>
<TI>Are special investigations of value in the management of patients with fecal incontinence?</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1997</YR>
<VL>40</VL>
<NO>8</NO>
<PG>896-901</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lam-1999" MODIFIED="2013-06-06 14:07:57 +0100" MODIFIED_BY="[Empty name]" NAME="Lam 1999" TYPE="JOURNAL_ARTICLE">
<AU>Lam TCF, Kennedy ML, Chen FC et al</AU>
<TI>Prevalence of Faecal incontinence: obstetric and constipation-related risk factors; a population-based study</TI>
<SO>Colorectal Disease</SO>
<YR>1999</YR>
<VL>1</VL>
<PG>197-203</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-MacArthur-1997" NAME="MacArthur 1997" NOTES="&lt;p&gt;MacArthur C, Bick DE, Keighley MR. Faecal incontinence after childbirth. Br J Obstet Gynaecol 1997; 104: 46-50.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>MacArthur C, Bick DE, Keighley MR</AU>
<TI>Faecal incontinence after childbirth</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>104</VL>
<PG>46-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maeda-2009" MODIFIED="2013-05-16 16:52:57 +0100" MODIFIED_BY="[Empty name]" NAME="Maeda 2009" TYPE="COCHRANE_REVIEW">
<AU>Maeda Y, Laurberg S, Norton C</AU>
<TI>Perianal injectable bulking agents as treatment for faecal incontinence in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2013</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-05-16 16:51:55 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-05-16 16:51:55 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD007959.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Malouf-2000" MODIFIED="2010-07-07 13:35:45 +0100" MODIFIED_BY="[Empty name]" NAME="Malouf 2000" TYPE="JOURNAL_ARTICLE">
<AU>Malouf AJ, Norton CS, Engel AF, Nicholls RJ, Kamm MA</AU>
<TI>Long-term results of overlapping anterior anal-sphincter repair for obstetrical trauma</TI>
<SO>Lancet</SO>
<YR>2000</YR>
<VL>355</VL>
<PG>260-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mellgren-1999" MODIFIED="2010-07-29 14:04:49 +0100" MODIFIED_BY="[Empty name]" NAME="Mellgren 1999" TYPE="JOURNAL_ARTICLE">
<AU>Mellgren A, Jenson LL et al</AU>
<TI>Long-term cost of fecal incontinence secondary to obstetric injuries</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1999</YR>
<VL>42</VL>
<NO>7</NO>
<PG>857-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Michot-2012" MODIFIED="2013-06-06 14:07:39 +0100" MODIFIED_BY="[Empty name]" NAME="Michot 2012" TYPE="UNPUBLISHED">
<AU>Michot F</AU>
<TI>Myoblast for anal incontinence</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2012</YR>
<IDENTIFIERS MODIFIED="2013-03-31 10:47:56 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-03-31 10:47:56 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT01523522"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mowatt-2007" MODIFIED="2013-05-16 16:34:58 +0100" MODIFIED_BY="[Empty name]" NAME="Mowatt 2007" TYPE="COCHRANE_REVIEW">
<AU>Mowatt G, Glazener CMA, Jarrett M</AU>
<TI>Sacral nerve stimulation for faecal incontinence and constipation in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2013-05-16 16:34:58 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-05-16 16:34:58 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004464.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nakayama-1997" NAME="Nakayama 1997" NOTES="&lt;p&gt;Nakayama H, Jorgensen HS, Pederson PM, Raaschou HO, Olsen TS. Prevalence and risk factors of Incontinence after stroke.  The Copenhagen stroke study.  Stroke 1997; 28(1): 58-62.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Nakayama H, Jorgensen HS, Pederson PM, Raaschou HO, Olsen TS</AU>
<TI>Prevalence and risk factors of Incontinence after stroke. The Copenhagen stroke study</TI>
<SO>Stroke</SO>
<YR>1997</YR>
<VL>28</VL>
<NO>1</NO>
<PG>58-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NCT01044589-2010" MODIFIED="2013-05-16 16:35:50 +0100" MODIFIED_BY="[Empty name]" NAME="NCT01044589 2010" TYPE="UNPUBLISHED">
<AU>Anonymous</AU>
<TI>Comparison of the efficacy of a biological implant to reinforce overlapping sphincter repair versus overlapping sphincter repair alone</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2010</YR>
<IDENTIFIERS MODIFIED="2013-03-31 11:07:24 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-03-31 11:07:24 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT01044589"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Nelson-1995" NAME="Nelson 1995" NOTES="&lt;p&gt;Nelson R, Norton N, Cautley E, Furner F. Community-based prevalence of anal incontinence. JAMA 1995; 274(7); 559-561.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Nelson R, Norton N, Cautley E, Furner F</AU>
<TI>Community-based prevalence of anal incontinence</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>274</VL>
<NO>7</NO>
<PG>559-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norderval-2012" MODIFIED="2013-05-16 16:56:28 +0100" MODIFIED_BY="[Empty name]" NAME="Norderval 2012" TYPE="UNPUBLISHED">
<AU>Norderval S, Rydningen M</AU>
<TI>A blinded randomized controlled clinical trial comparing sacral nerve modulation and anal bulking injections as treatment for fecal incontinence after obstetric anal sphincter injuries (OASIS)</TI>
<SO>ClinicalTrials.gov</SO>
<YR>2012</YR>
<IDENTIFIERS MODIFIED="2013-03-31 11:10:14 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-03-31 11:10:14 +0100" MODIFIED_BY="[Empty name]" TYPE="OTHER" VALUE="NCT01528995"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Parellada-1998" NAME="Parellada 1998" NOTES="&lt;p&gt;Parellada CM, Miller AS, Williamson MER, Johnston D. Paradoxical high anal resting pressures in men with idiopathic fecal seepage. Dis Colon Rectum 1998; 41(5): 593-7.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Parellada CM, Miller AS, Williamson MER, Johnston D</AU>
<TI>Paradoxical high anal resting pressures in men with idiopathic fecal seepage</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1998</YR>
<VL>41</VL>
<NO>5</NO>
<PG>593-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Parks-1975" MODIFIED="2009-11-11 09:40:42 +0000" MODIFIED_BY="[Empty name]" NAME="Parks 1975" NOTES="&lt;p&gt;Parks AG Anorectal incontinnce. Proc R Soc Med 1975;68:681-90.&lt;/p&gt;" NOTES_MODIFIED="2009-11-11 09:40:42 +0000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Parks AG</AU>
<TI>Anorectal incontinence</TI>
<SO>Proceedings of the Royal Society of Medicine</SO>
<YR>1975</YR>
<VL>68</VL>
<PG>681-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Perry-2002" MODIFIED="2009-11-11 09:59:40 +0000" MODIFIED_BY="[Empty name]" NAME="Perry 2002" TYPE="JOURNAL_ARTICLE">
<AU>Perry S, Shaw C, Varma MG, et al</AU>
<TI>Prevalence of faecal incontinence in adults aged 40 years or more living in the community</TI>
<SO>Gut</SO>
<YR>2002</YR>
<VL>50</VL>
<PG>480-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pescatori-2004" MODIFIED="2010-07-07 13:36:28 +0100" MODIFIED_BY="[Empty name]" NAME="Pescatori 2004" TYPE="JOURNAL_ARTICLE">
<AU>Pescatori M</AU>
<TI>Systematic review of sacral nerve stimulation for faecal incontinence and constipation</TI>
<SO>British Journal of Surgery</SO>
<YR>2004</YR>
<VL>91</VL>
<PG>1559-69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pfeifer-1997" NAME="Pfeifer 1997" NOTES="&lt;p&gt;Pfeifer J, Salanga VD, Agachan F, Weiss EG, Wexner SD. Variation in Pudendal nerve terminal motor latency according to disease. Dis Colon Rectum 1997;40(1):79-83.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Pfeifer J, Salanga VD, Agachan F, Weiss EG, Wexner SD</AU>
<TI>Variation in pudendal nerve terminal motor latency according to disease</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1997</YR>
<VL>40</VL>
<NO>1</NO>
<PG>79-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rainey-1990" NAME="Rainey 1990" NOTES="&lt;p&gt;Rainey JB, Donaldson DR, Thompson JPS. Postanal repair: which patients derive most benefit. J R Coll Surg Edinb 1990; 35: 101-5.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Rainey JB, Donaldson DR, Thompson JPS</AU>
<TI>Postanal repair: which patients derive most benefit?</TI>
<SO>Journal of the Royal College of Surgeons of Edinburgh</SO>
<YR>1990</YR>
<VL>35</VL>
<PG>101-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rockwood-2000" MODIFIED="2010-07-07 13:36:47 +0100" MODIFIED_BY="[Empty name]" NAME="Rockwood 2000" TYPE="JOURNAL_ARTICLE">
<AU>Rockwood TH, Church JM, Fleshman JW, Kane RL, Mavrontonis SC, Thorson AG, et al</AU>
<TI>Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2000</YR>
<VL>43</VL>
<PG>9-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ryhammer-1997" NAME="Ryhammer 1997" NOTES="&lt;p&gt;Ryhammer AM, Laurberg S, Hermann AP. Test-retest repeatability of anorectal physiology tests in healthy volunteers. Dis Colon and Rectum1997;40(3): 287-92.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Ryhammer AM, Laurberg S, Hermann AP</AU>
<TI>Test-retest repeatability of anorectal physiology tests in healthy volunteers</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1997</YR>
<VL>40</VL>
<NO>3</NO>
<PG>287-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Setti-Carraro-1994" NAME="Setti Carraro 1994" NOTES="&lt;p&gt;Setti P, Carraro M, Kamm MA, Nicholls RJ. Postanal repair of neurogenic faecal incontinence. Br J Surg 1994, 81: 140-44.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Setti Carraro P, Kamm MA, Nicholls RJ</AU>
<TI>Long-term results of postanal repair of neurogenic faecal incontinence</TI>
<SO>British Journal of Surgery</SO>
<YR>1994</YR>
<VL>81</VL>
<NO>1</NO>
<PG>140-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Siproudhis-2006" MODIFIED="2010-07-07 13:37:02 +0100" MODIFIED_BY="[Empty name]" NAME="Siproudhis 2006" TYPE="JOURNAL_ARTICLE">
<AU>Siproudhis L, Pigot F, Godeberge P et al</AU>
<TI>Defecation disorders: A French population survey</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2006</YR>
<VL>49</VL>
<PG>219-27</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sun-1990" NAME="Sun 1990" NOTES="&lt;p&gt;Sun WM, Read NW, Miner PB. Relation between rectal sensation and anal function in normal subjects and patients with fecal incontinence. Gut 1990; 31(9): 1056-61.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Sun WM, Read NW, Miner PB</AU>
<TI>Relation between rectal sensation and anal function in normal subjects and patients with fecal incontinence</TI>
<SO>Gut</SO>
<YR>1990</YR>
<VL>31</VL>
<NO>9</NO>
<PG>1056-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Takahashi-2002" MODIFIED="2013-06-06 08:16:47 +0100" MODIFIED_BY="[Empty name]" NAME="Takahashi 2002" TYPE="JOURNAL_ARTICLE">
<AU>Takahashi T, Garcia-Osogobio S, Valdovinos MA, Mass W, Jimenez R, Jauregui LA, et al</AU>
<TI>Radio-frequency energy delivery to the anal canal for the treatment of fecal incontinence</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2002</YR>
<VL>45</VL>
<PG>915-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tou-2008" MODIFIED="2009-11-11 10:06:00 +0000" MODIFIED_BY="[Empty name]" NAME="Tou 2008" TYPE="COCHRANE_REVIEW">
<AU>Tou S, Brown SR, Malik AI, Nelson RL</AU>
<TI>Surgery for complete rectal prolapse in adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2009-11-11 09:53:03 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-11 09:53:03 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001758.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Turnberg-1995" MODIFIED="2013-06-06 08:17:06 +0100" MODIFIED_BY="[Empty name]" NAME="Turnberg 1995" NOTES="&lt;p&gt;Turnberg L, Brocklehurst J, Fowler C, Borzyskowski M, Cardozo L, Chellingsworth M. et al A report of the Royal College of Physicans. Incontinence Causes, Management and Provision of services. The Royal College of Physicans of London, 1995.&lt;/p&gt;" NOTES_MODIFIED="2013-06-06 08:17:06 +0100" NOTES_MODIFIED_BY="[Empty name]" TYPE="BOOK">
<AU>Turnberg L, Brocklehurst J, Fowler C, Borzyskowski M, Cardozo L, Chellingsworth M, et al</AU>
<SO>Incontinence. Causes, management and provision of services</SO>
<YR>1995</YR>
<EN>May</EN>
<PB>The Royal College of Physicians</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Uher-1998" NAME="Uher 1998" NOTES="&lt;p&gt;Uher EM, Swash M. Sacral reflexes physiology and clinical application. Dis Colon Rectum 1998; 41(9): 1165-1177.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Uher EM, Swash M</AU>
<TI>Sacral reflexes physiology and clinical application</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>1998</YR>
<VL>41</VL>
<NO>9</NO>
<PG>1165-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vaizey-1998" NAME="Vaizey 1998" NOTES="&lt;p&gt;Vaizey CJ, Kamm MA, Nicholls RJ. Recent advances in the surgical treatment of faecal incontinence. Br J Surg1998, 85: 596-603.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Vaizey CJ, Kamm MA, Nicholls RJ</AU>
<TI>Recent advances in the surgical treatment of faecal incontinence</TI>
<SO>British Journal of Surgery</SO>
<YR>85</YR>
<VL>5</VL>
<PG>596-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ware-1993" NAME="Ware 1993" TYPE="BOOK">
<AU>Ware JE, Snow KK, Kosinski M, Gandek B</AU>
<SO>SF-36 Health Survey Manual and Interpretation Guide</SO>
<YR>1993</YR>
<PB>New England Medical Centre</PB>
<CY>Boston</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whitehead-2009" MODIFIED="2013-06-06 08:17:29 +0100" MODIFIED_BY="[Empty name]" NAME="Whitehead 2009" TYPE="JOURNAL_ARTICLE">
<AU>Whitehead WE, Borrud L, Goode PS, et al</AU>
<TI>Fecal incontinence in US adults: epidemiology and risk factors</TI>
<SO>Gastroenterology</SO>
<YR>2009</YR>
<VL>137</VL>
<NO>2</NO>
<PG>512-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wong-2011" MODIFIED="2013-06-06 14:07:29 +0100" MODIFIED_BY="[Empty name]" NAME="Wong 2011" TYPE="JOURNAL_ARTICLE">
<AU>Wong MTC, Meurette G, Stanherlin P, Lehur PA</AU>
<TI>The magnetic anal sphincter versus the artificial bowel sphincter: a comparison of 2 treatments for fecal incontinence
</TI>
<SO>Diseases of the Colon and Rectum</SO>
<YR>2011</YR>
<VL>54</VL>
<PG>773-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zigmond-1983" NAME="Zigmond 1983" TYPE="JOURNAL_ARTICLE">
<AU>Zigmond AS, Snaith RP</AU>
<TI>The Hospital Anxiety and Depression Scale</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1983</YR>
<VL>67</VL>
<PG>361-70</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-06-06 13:59:46 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-06-06 13:59:40 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-06-06 13:58:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Davis-2004">
<CHAR_METHODS MODIFIED="2013-06-06 13:58:53 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: 'random numbers'<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: 4 postponed surgery. 10 declined study. 2 lost to follow-up<BR/>Intention-to-treat: unclear<BR/>Follow-up period: 12 months<BR/>Setting: single centre, UK<BR/>Exclusion criteria: prolapse, congenital abnormality, IBD, non-obstetric trauma, neuropathy, &lt;18 years, planning pregnancy</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Sample size = 31 <BR/>Mean age = 60 years<BR/>(range 26-78 years) <BR/>Female patients with endosonographically identifiable external sphincter defect</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-04-23 02:19:37 +0100" MODIFIED_BY="[Empty name]">
<P>Overlap sphincter repair versus sphincter repair and biofeedback</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-06 13:58:56 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcomes:<BR/>- no change in incontinence<BR/>- failing to achieve full continence<BR/>Secondary outcomes:<BR/>- incontinence score<BR/>- patient satisfaction score<BR/>- quality of life score (generic)<BR/>- physiological outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deen-1993">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:00 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random number tables<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: none<BR/>Intention-to-treat: yes<BR/>Follow-up period: 2 years (median)<BR/>Setting: single centre, United Kingdom<BR/>Exclusion criteria: patients with co-morbidity (diabetes) and endosonographic sphincter defect</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Sample size = 36 <BR/>Mean age = 51 years<BR/>(range 28-75 years) <BR/>Female patients with neuropathic faecal incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-05-10 15:39:40 +0100" MODIFIED_BY="[Empty name]">
<P>Anterior levatorplasty versus postanal repair versus total pelvic floor repair</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcomes:<BR/>- no change in incontinence <BR/>- failing to achieve full continence<BR/>Secondary outcomes:<BR/>- adverse functional effects <BR/>- physiological outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deen-1995">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:08 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random number tables<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: none<BR/>Intention-to-treat: yes<BR/>Follow-up period (mean): 15.4(±5.5) months for pelvic floor repair alone, 16.8 (±4.5) months for adjuvant internal anal sphincter plication<BR/>pelvic floor repair group = 15.4 months (SD 5.5)<BR/>+ internal sphincter plication group = 16.8 months (SD 4.5)<BR/>Setting: single centre, UK<BR/>Exclusion criteria: patients with co-morbidity (diabetes) and endosonographic sphincter defect</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Sample size = 30<BR/>Mean age 57.5 years (range 27-72 years)<BR/>Female patients with neuropathic faecal incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Pelvic floor repair versus pelvic floor repair with internal sphincter plication</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcome measures: <BR/>- none reported <BR/>Secondary outcome measures:<BR/>- incontinence scores<BR/>- physiological outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hasegawa-2000">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:10 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: unclear<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: 4 refused to have a stoma. 2 patients given a stoma by the surgeon irrespective of randomisation<BR/>Intention-to-treat: yes<BR/>Follow-up period: mean 34 months (range 16-47 months)<BR/>Setting: single centre, UK<BR/>Exclusion criteria: nil</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-06 13:59:12 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size = 27<BR/>Median age = 48 years<BR/>(range 23-76 years)<BR/>Patients with localised sphincter damage</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-04-23 02:19:44 +0100" MODIFIED_BY="[Empty name]">
<P>Overlap sphincter repair versus repair and defunctioning</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-06 13:59:12 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome measures:<BR/>- none reported<BR/>Secondary outcome measures:<BR/>- incontinence scores<BR/>- physiological scores<BR/>- complications<BR/>- hospital stay</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Trial closed early due to high complication rate related to the stoma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Brien-2004">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: computer generated random numbers<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: none<BR/>Intention-to-treat: unclear<BR/>Follow-up period: 6 months<BR/>Setting: single centre, Australia<BR/>Exclusion criteria: patients with previous sphincter repair or endosonographically unrepairable sphincter</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-06 13:59:15 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size = 14<BR/>Median age = 63 years<BR/>(range 44-75 years)<BR/>Patients with neurogenic faecal incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-04-23 02:19:52 +0100" MODIFIED_BY="[Empty name]">
<P>Artificial bowel sphincter versus best supportive care</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-06-06 13:59:17 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome measures:<BR/>- none reported<BR/>Secondary outcomes:<BR/>- incontinence scores<BR/>- quality of life scores (generic and specific)<BR/>- complications</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Osterberg--2004">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:18 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random block<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: 11 (7 from control group)<BR/>Intention-to-treat: unclear<BR/>Follow-up period: 2 years<BR/>Setting: single centre, Sweden<BR/>Exclusion criteria: patients with an endosonographic sphincter defect, rectal prolapse or intra-anal intussusception</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Sample size = 59 <BR/>Median age = 66 years<BR/>(range 43-81 years) <BR/>Patients with neuropathic faecal incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-06 13:59:19 +0100" MODIFIED_BY="[Empty name]">
<P>Anterior levatoroplasty versus anal plug stimulation</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcomes:<BR/>- no change in incontinence<BR/>Secondary outcomes:<BR/>- use of pads<BR/>- complications<BR/>- physiological outcomes<BR/>- incontinence score<BR/>- patient assessment of handicap</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tjandra-2003">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:25 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: unclear<BR/>Blinding: participants blinded to repair. No mention of blinding of surgeons or outcome assessors<BR/>Withdrawals: none<BR/>Intention-to-treat: yes<BR/>Follow-up period: median 18 months (range 10-34 months)<BR/>Setting: single centre, Australia<BR/>Exclusion criteria: patients with prolonged pudendal nerve terminal motor latency</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-06 13:59:25 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size = 23<BR/>Median age = 46 years (range 31-71 years)<BR/>Women with localised anterior defect of external sphincter after obstetric damage</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-06 13:59:28 +0100" MODIFIED_BY="[Empty name]">
<P>Overlap sphincter repair versus direct end to end repair</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcomes:<BR/>- no change in incontinence<BR/>Secondary outcomes:<BR/>- adverse function<BR/>- complications<BR/>- physiological outcomes<BR/>- incontinence score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-van-Tets-1998">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:33 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random lots<BR/>Blinding: no mention of blinding for participants, surgeons or outcome assessors<BR/>Withdrawals: none<BR/>Intention-to-treat: yes<BR/>Follow-up period, mean 3.5 years (range 1.5-5)<BR/>Setting: single centre, the Netherlands<BR/>Exclusion criteria:<BR/>patients with endosonographic sphincter defect</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-06 07:44:31 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size = 20 </P>
<P>Mean age 55 year (range 34-74 years)<BR/>Female patients with neuropathic faecal incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-06 13:59:34 +0100" MODIFIED_BY="[Empty name]">
<P>Postanal repair versus total pelvic floor repair</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcome measures:<BR/>- no change in incontinence <BR/>Secondary outcome measures:<BR/>- physiological outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-06-06 13:59:35 +0100" MODIFIED_BY="[Empty name]">
<P>Authors contacted regarding details of randomisation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-06-06 13:59:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yoshioka-1999">
<CHAR_METHODS MODIFIED="2013-06-06 13:59:37 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: random block<BR/>Blinding: no mention of blinding of participants, surgeons or outcome assessors<BR/>Withdrawals: none<BR/>Intention-to-treat: yes<BR/>Follow-up period: 18 months<BR/>Setting: single centre, UK<BR/>Exclusion criteria: patients with co-morbidity (diabetes) and endosonographic sphincter defect</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-06-06 13:59:38 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size = 24<BR/>Mean age = 60 years (range 30-77 years)<BR/>Female patients with neuropathic faecal incontinence</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-06-06 13:59:40 +0100" MODIFIED_BY="[Empty name]">
<P>Total pelvic floor repair versus gluteus maximus transposition (without electrical stimulation)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Primary outcome:<BR/>- failing to achieve full continence<BR/>- faecal urgency<BR/>Secondary outcome measures:<BR/>- post-operative complications<BR/>- adverse functional effects<BR/>- physiological outcomes</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Pilot study</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-06-06 13:59:46 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dehli-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:41 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-30 07:48:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farrell-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-30 07:48:01 +0000" MODIFIED_BY="[Empty name]">
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-30 07:48:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Farrell-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-30 07:48:03 +0000" MODIFIED_BY="[Empty name]">
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-06 23:55:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fernando-2006a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-06 23:55:13 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fitzpatrick-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garcia-V-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Graf-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:42 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-12 09:00:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leroi-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-12 09:00:30 +0100" MODIFIED_BY="[Empty name]">
<P>Sacral nerve stimulation is analysed in another Cochrane review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Loder-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:43 +0100" MODIFIED_BY="[Empty name]">
<P>No RCT or clinical trial. Letter published in a journal</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Maeda-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:44 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-30 07:49:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Michelsen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-30 07:49:04 +0000" MODIFIED_BY="[Empty name]">
<P>Sacral nerve stimulation is analysed in another Cochrane review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-09-06 23:55:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nordenstam-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-09-06 23:55:36 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rygh-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:44 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Siphrouis-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:45 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tjandra-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:46 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-30 07:51:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tjandra-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-30 07:51:09 +0000" MODIFIED_BY="[Empty name]">
<P>Sacral nerve stimulation is analysed in another Cochrane review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-06-06 13:59:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tjandra-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-06-06 13:59:46 +0100" MODIFIED_BY="[Empty name]">
<P>Study looking at bulking agents. Relevant to another review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-05-12 09:00:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vaizey-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-05-12 09:00:43 +0100" MODIFIED_BY="[Empty name]">
<P>Sacral nerve stimulation is analysed in another Cochrane review</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Williams-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Study looking at acute obstetric injury repair. Patients not incontinent before repair</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-01-29 11:56:09 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-01-29 11:56:09 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Davis-2004">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Deen-1993">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Deen-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hasegawa-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-09-29 06:44:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Brien-2004">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Osterberg--2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Tjandra-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Yoshioka-1999">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-van-Tets-1998">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-06-06 14:07:20 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-06-06 14:07:20 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Anterior levatorplasty versus anal plug electrostimulation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-11 09:55:49 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="13.01" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1>levatorplasty</GROUP_LABEL_1>
<GROUP_LABEL_2>anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4071361973268597" CI_START="0.11713302540538585" EFFECT_SIZE="0.405982905982906" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.14833613502170223" LOG_CI_START="-0.9313206392642923" LOG_EFFECT_SIZE="-0.39149225212129507" ORDER="1" O_E="0.0" SE="0.6341957336028191" STUDY_ID="STD-Osterberg--2004" TOTAL_1="31" TOTAL_2="28" VAR="0.40220422852001797" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:46:42 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1>Levatorplasty</GROUP_LABEL_1>
<GROUP_LABEL_2>anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:46:49 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1>Levatorplasty</GROUP_LABEL_1>
<GROUP_LABEL_2>anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:42:59 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="13.523475801745153" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients using pads</NAME>
<GROUP_LABEL_1>Levatorplasty</GROUP_LABEL_1>
<GROUP_LABEL_2>anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1884288807673076" CI_START="0.1433152480557545" EFFECT_SIZE="0.4126984126984127" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="15" LOG_CI_END="0.0749731973267365" LOG_CI_START="-0.843707600292264" LOG_EFFECT_SIZE="-0.38436720148276377" ORDER="2" O_E="0.0" SE="0.539637648064691" STUDY_ID="STD-Osterberg--2004" TOTAL_1="31" TOTAL_2="28" VAR="0.29120879120879123" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:45:53 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="205.84727468480568" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with complications</NAME>
<GROUP_LABEL_1>Levatorplast</GROUP_LABEL_1>
<GROUP_LABEL_2>Anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="71.65579501270857" CI_START="0.10966833044197495" EFFECT_SIZE="2.80327868852459" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8552513188125122" LOG_CI_START="-0.9599187680497387" LOG_EFFECT_SIZE="0.44766627538138676" ORDER="7" O_E="0.0" SE="1.653644844339562" STUDY_ID="STD-Osterberg--2004" TOTAL_1="31" TOTAL_2="28" VAR="2.734541271210814" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:45:53 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="33.53618139687021" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Patient assessment of physical handicap (yes/no)</NAME>
<GROUP_LABEL_1>Levatorplasty</GROUP_LABEL_1>
<GROUP_LABEL_2>Anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5875610205839016" CI_START="0.06390936429991739" EFFECT_SIZE="0.1937799043062201" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="19" LOG_CI_END="-0.2309470234788466" LOG_CI_START="-1.1944355023139241" LOG_EFFECT_SIZE="-0.7126912628963854" ORDER="8" O_E="0.0" SE="0.5659579018126137" STUDY_ID="STD-Osterberg--2004" TOTAL_1="31" TOTAL_2="28" VAR="0.3203083466241361" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:45:53 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="358.57319815393186" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Patient assessment of social handicap (yes/no)</NAME>
<GROUP_LABEL_1>Levatorplasty</GROUP_LABEL_1>
<GROUP_LABEL_2>Anal plug</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.2906347275836193" CI_START="0.009852582549896459" EFFECT_SIZE="0.05351170568561873" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="-0.5366524936276904" LOG_CI_START="-2.0064499177093196" LOG_EFFECT_SIZE="-1.2715512056685048" ORDER="9" O_E="0.0" SE="0.8633662825201377" STUDY_ID="STD-Osterberg--2004" TOTAL_1="31" TOTAL_2="15" VAR="0.7454013377926422" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-06-06 14:07:14 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Artificial bowel sphincter versus best supportive care</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:46:11 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5214885995952881" CI_START="6.042606055544644E-4" EFFECT_SIZE="0.01775147928994083" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="-0.2827551813639632" LOG_CI_START="-3.2187757184240584" LOG_EFFECT_SIZE="-1.750765449894011" ORDER="10" O_E="0.0" SE="1.7246329970051524" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="6" TOTAL_2="7" VAR="2.974358974358974" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:46:58 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1>Artifical sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:47:05 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2010-05-10 14:54:32 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.629186490770028" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Cleveland Clinic Continence Score</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-4.8249522543994825" CI_START="-14.175047745600518" EFFECT_SIZE="-9.5" ESTIMABLE="YES" MEAN_1="4.8" MEAN_2="14.3" ORDER="12" SD_1="4.0" SD_2="4.6" SE="2.38527227157065" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2010-05-10 14:54:33 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="67.42741860899464" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life score</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="50.281445664994195" CI_START="5.7185543350058055" EFFECT_SIZE="28.0" ESTIMABLE="YES" MEAN_1="82.7" MEAN_2="54.7" ORDER="13" SD_1="14.0" SD_2="26.0" SE="11.368293418015531" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2010-05-10 14:54:34 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="15.131708291821687" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Physical assessment (SF-36)</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="13.888087444859647" CI_START="-5.8880874448596465" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="45.0" MEAN_2="41.0" ORDER="14" SD_1="7.0" SD_2="11.0" SE="5.045035277615108" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2010-05-10 14:54:35 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="20.63" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Mental assessment (SF-36)</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours control</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours treatment</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.495241156134291" CI_START="2.7047588438657115" EFFECT_SIZE="7.600000000000001" ESTIMABLE="YES" MEAN_1="52.0" MEAN_2="44.4" ORDER="15" SD_1="4.0" SD_2="5.0" SE="2.4976179127511156" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2010-05-10 14:54:36 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="25.449315515463425" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Beck depression score</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="16.831392802141632" CI_START="-3.8313928021416324" EFFECT_SIZE="6.5" ESTIMABLE="YES" MEAN_1="6.8" MEAN_2="0.3" ORDER="16" SD_1="9.0" SD_2="10.0" SE="5.271215636427169" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-002.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 14:54:36 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="7" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with complications</NAME>
<GROUP_LABEL_1>Artificial sphincter</GROUP_LABEL_1>
<GROUP_LABEL_2>Conservative</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="282.0448513702082" CI_START="0.4825867604030593" EFFECT_SIZE="11.666666666666666" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.4503181762403994" LOG_CI_START="-0.316424596979173" LOG_EFFECT_SIZE="1.066946789630613" ORDER="11" O_E="0.0" SE="1.625198400586784" STUDY_ID="STD-O_x0027_Brien-2004" TOTAL_1="7" TOTAL_2="7" VAR="2.641269841269841" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2013-06-06 14:07:08 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Anterior levatorplasty versus postanal repair</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2010-05-10 15:27:44 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:28:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="59.32911507186519" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.090303069038073" CI_START="0.278803902101282" EFFECT_SIZE="1.405988678022874" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.8506647991319821" LOG_CI_START="-0.5547011522053216" LOG_EFFECT_SIZE="0.14798182346333022" ORDER="29" O_E="0.5" SE="0.8255189164891871" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" VAR="1.4673913043478262" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:28:28 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="132.92788101468818" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with dyspareunia</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="77.4646392137161" CI_START="1.6360481988244597" EFFECT_SIZE="11.25770329410874" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="1.8891035025207739" LOG_CI_START="0.21379609406339292" LOG_EFFECT_SIZE="1.0514497982920834" ORDER="30" O_E="2.5" SE="0.9840838646332837" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" VAR="1.0326086956521738" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.05" MODIFIED="2010-05-10 15:29:17 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="70.31896765685232" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum resting anal pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<CONT_DATA CI_END="32.385078357454375" CI_START="-12.385078357454375" EFFECT_SIZE="10.0" ESTIMABLE="YES" MEAN_1="-74.0" MEAN_2="-84.0" ORDER="31" SD_1="24.29" SD_2="31.23" SE="11.42116821228605" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.06" MODIFIED="2010-05-10 15:29:36 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="106.7025154200236" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum squeeze pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<CONT_DATA CI_END="20.72235333002471" CI_START="-56.72235333002471" EFFECT_SIZE="-18.0" ESTIMABLE="YES" MEAN_1="-141.0" MEAN_2="-123.0" ORDER="32" SD_1="58.99" SD_2="34.7" SE="19.75666575276979" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-003.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:29:52 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in anal canal sensation (mA)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.6832064673498914" CI_START="0.008258301584349217" EFFECT_SIZE="0.14885808080333315" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.4286540920460689" LOG_CI_START="-2.083109261201314" LOG_EFFECT_SIZE="-0.8272275845776225" ORDER="33" O_E="-0.875" SE="1.4754222271266348" STUDY_ID="STD-Deen-1993" TOTAL_1="9" TOTAL_2="7" VAR="0.45937500000000003" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.08" MODIFIED="2010-05-10 15:30:09 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="3.9755440046649144" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Functional length of anal canal (cm)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>AL</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.34207501085079883" CI_START="-1.9420750108507985" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="-3.9" MEAN_2="-3.1" ORDER="34" SD_1="1.73" SD_2="1.04" SE="0.5827020393534476" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2013-06-06 14:07:01 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Total pelvic floor repair versus anterior levatorplasty</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:30:33 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:30:45 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="189.86925919928888" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.334867094869339" CI_START="0.058169897214431214" EFFECT_SIZE="0.27865584814153077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="8" LOG_CI_END="0.12543802761955153" LOG_CI_START="-1.2353017035945286" LOG_EFFECT_SIZE="-0.5549318379874885" ORDER="35" O_E="-2.0" SE="0.7993052538854533" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" VAR="1.5652173913043477" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:31:02 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:31:17 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="54.678257328025765" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with dyspareunia</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.8980248485602" CI_START="0.20416392952639983" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.6900209840482306" LOG_CI_START="-0.6900209840482308" LOG_EFFECT_SIZE="0.0" ORDER="36" O_E="0.0" SE="0.8106434833777776" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" VAR="1.5217391304347825" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.05" MODIFIED="2010-05-10 15:31:42 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="57.45342863799044" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum resting anal pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.435690769778418" CI_START="-30.435690769778418" EFFECT_SIZE="-11.0" ESTIMABLE="YES" MEAN_1="-85.0" MEAN_2="-74.0" ORDER="37" SD_1="24.29" SD_2="24.29" SE="9.916350975367234" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.06" MODIFIED="2010-05-10 15:31:54 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="79.73308486465162" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum squeeze pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
<CONT_DATA CI_END="48.72235333002471" CI_START="-28.72235333002471" EFFECT_SIZE="10.0" ESTIMABLE="YES" MEAN_1="-131.0" MEAN_2="-141.0" ORDER="38" SD_1="34.7" SD_2="58.99" SE="19.75666575276979" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-004.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:32:10 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in anal canal sensation (mA)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
<DICH_DATA CI_END="162.62049800841103" CI_START="0.5374975818433341" EFFECT_SIZE="9.349231221746507" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="2.211175286712344" LOG_CI_START="-0.2696234852625129" LOG_EFFECT_SIZE="0.9707759007249157" ORDER="39" O_E="1.0526315789473681" SE="1.457233478810004" STUDY_ID="STD-Deen-1993" TOTAL_1="10" TOTAL_2="9" VAR="0.47091412742382266" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.08" MODIFIED="2010-05-10 15:32:21 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.173376197852419" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Functional length of anal canal (cm)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>AL</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7343317809224692" CI_START="-2.3343317809224695" EFFECT_SIZE="-0.8000000000000003" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-3.9" ORDER="40" SD_1="2.08" SD_2="1.74" SE="0.7828367220138139" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-06-06 14:06:56 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Total pelvic floor repair (TPFR) versus postanal repair (PAR)</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:44:06 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="9" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.5711160134099047" CI_START="0.10726272123074847" EFFECT_SIZE="0.6189084111797548" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.552803959172154" LOG_CI_START="-0.9695511892813348" LOG_EFFECT_SIZE="-0.2083736150545904" ORDER="41" O_E="-0.5999999999999996" SE="0.8942389499810995" STUDY_ID="STD-van-Tets-1998" TOTAL_1="11" TOTAL_2="9" VAR="1.250526315789474" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.8349966536510327" CI_START="0.07909444866074922" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.3809698788813208" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="0.2636352765977996" LOG_CI_START="-1.1018539969145653" LOG_EFFECT_SIZE="-0.41910936015838285" METHOD="PETO" MODIFIED="2010-05-10 15:44:17 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.22892111134049653" Q="0.0" RANDOM="NO" SCALE="99.99864506187409" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="23" WEIGHT="100.0" Z="1.203142737813119">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.8349966536510327" CI_START="0.07909444866074922" EFFECT_SIZE="0.3809698788813208" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.2636352765977996" LOG_CI_START="-1.1018539969145653" LOG_EFFECT_SIZE="-0.41910936015838285" ORDER="43" O_E="-1.5" SE="0.8020951585420794" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" VAR="1.5543478260869565" WEIGHT="100.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="11" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="42" O_E="0.0" SE="0.0" STUDY_ID="STD-van-Tets-1998" TOTAL_1="9" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:44:33 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="358.57319815393186" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with adverse functional effects</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="77.4646392137161" CI_START="1.6360481988244597" EFFECT_SIZE="11.25770329410874" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="0" LOG_CI_END="1.8891035025207739" LOG_CI_START="0.21379609406339292" LOG_EFFECT_SIZE="1.0514497982920834" ORDER="44" O_E="2.5" SE="0.9840838646332837" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" VAR="1.0326086956521738" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.05" MODIFIED="2010-05-10 15:45:01 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="48.4993433058706" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum resting anal pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<CONT_DATA CI_END="21.385078357454375" CI_START="-23.385078357454375" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-85.0" MEAN_2="-84.0" ORDER="45" SD_1="24.29" SD_2="31.23" SE="11.42116821228605" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.06" MODIFIED="2010-05-10 15:45:10 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum squeeze pressure</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<CONT_DATA CI_END="19.765272528254883" CI_START="-35.76527252825488" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-131.0" MEAN_2="-123.0" ORDER="46" SD_1="34.7" SD_2="34.7" SE="14.166215679096048" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-005.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:45:23 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="10" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in anal canal sensation (mA)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="47" O_E="0.0" SE="0.0" STUDY_ID="STD-Deen-1993" TOTAL_1="10" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.08" MODIFIED="2010-05-10 15:46:18 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.173376197852419" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Functional length of anal canal (cm)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.2842426356430734" CI_START="-2.915757364356927" EFFECT_SIZE="-1.6" ESTIMABLE="YES" MEAN_1="-4.7" MEAN_2="-3.1" ORDER="48" SD_1="2.08" SD_2="1.04" SE="0.671317113342619" STUDY_ID="STD-Deen-1993" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 15:47:04 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="455.79042944652963" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="9" TOTAL_2="11" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with a decrease in maximum squeeze pressure</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR</GRAPH_LABEL_1>
<GRAPH_LABEL_2>PAR</GRAPH_LABEL_2>
<DICH_DATA CI_END="15.652074384531744" CI_START="0.29663586938303443" EFFECT_SIZE="2.1547544390726983" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="1.1945719031639168" LOG_CI_START="-0.5277763349892273" LOG_EFFECT_SIZE="0.33339778408734483" ORDER="49" O_E="0.75" SE="1.0117158808524374" STUDY_ID="STD-van-Tets-1998" TOTAL_1="9" TOTAL_2="11" VAR="0.9769736842105264" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2013-06-06 14:06:49 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Overlap sphincter repair versus end to end repair</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 15:47:40 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="33.53618139687021" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1>Overlap repair</GROUP_LABEL_1>
<GROUP_LABEL_2>end to end repair</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.242998972603397" CI_START="0.17473770254382462" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.8599184235974151" LOG_CI_START="-0.7576133787026526" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="50" O_E="0.0" SE="0.9501461875826149" STUDY_ID="STD-Tjandra-2003" TOTAL_1="11" TOTAL_2="12" VAR="0.9027777777777777" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1>Overlap repair</GROUP_LABEL_1>
<GROUP_LABEL_2>end-to-end repair</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1>Overlap repair</GROUP_LABEL_1>
<GROUP_LABEL_2>end-to-end repair</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 15:50:39 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="16.43200336024396" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients having to use imodium</NAME>
<GROUP_LABEL_1>Overlap repair</GROUP_LABEL_1>
<GROUP_LABEL_2>End-to-end repair</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.298327814241254" CI_START="0.32936029587056453" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.9684048532480614" LOG_CI_START="-0.4823287558754725" LOG_EFFECT_SIZE="0.24303804868629444" ORDER="52" O_E="0.0" SE="0.8521681032463466" STUDY_ID="STD-Tjandra-2003" TOTAL_1="11" TOTAL_2="12" VAR="0.7261904761904762" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 15:50:54 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="513.712487043582" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with difficulty evacuating</NAME>
<GROUP_LABEL_1>Overlap repair</GROUP_LABEL_1>
<GROUP_LABEL_2>End-to-end repair</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="153.73841372776235" CI_START="0.28153372619739886" EFFECT_SIZE="6.578947368421052" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.1867823957079224" LOG_CI_START="-0.5504695715974676" LOG_EFFECT_SIZE="0.8181564120552274" ORDER="53" O_E="0.0" SE="1.6078753552109495" STUDY_ID="STD-Tjandra-2003" TOTAL_1="11" TOTAL_2="12" VAR="2.5852631578947367" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 15:51:10 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="182.34548480923007" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="11" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Complications</NAME>
<GROUP_LABEL_1>Overlap repair</GROUP_LABEL_1>
<GROUP_LABEL_2>End-to-end repair</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="68.42310139003123" CI_START="0.5774395383865049" EFFECT_SIZE="6.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.835202755409563" LOG_CI_START="-0.23849348246570173" LOG_EFFECT_SIZE="0.7983546364719306" ORDER="54" O_E="0.0" SE="1.218099435089859" STUDY_ID="STD-Tjandra-2003" TOTAL_1="11" TOTAL_2="12" VAR="1.4837662337662336" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2013-06-06 14:06:41 +0100" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Overlap sphincter repair versus repair and defunctioning</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1>repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.04" MODIFIED="2010-05-10 15:59:09 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Cleveland Clinic Continence Score</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.450437493811097" CI_START="-2.8504374938110972" EFFECT_SIZE="1.7999999999999998" ESTIMABLE="YES" MEAN_1="9.6" MEAN_2="7.8" ORDER="55" SD_1="6.8" SD_2="5.5" SE="2.3727157899293836" STUDY_ID="STD-Hasegawa-2000" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.05" MODIFIED="2010-05-10 15:59:19 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="33.001989405845165" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum resting pressure</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="20.940346422765113" CI_START="-12.940346422765113" EFFECT_SIZE="4.0" ESTIMABLE="YES" MEAN_1="71.3" MEAN_2="67.3" ORDER="56" SD_1="12.1" SD_2="28.9" SE="8.643192709860182" STUDY_ID="STD-Hasegawa-2000" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.06" MODIFIED="2010-05-10 15:59:31 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="39.187128011115725" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum squeeze pressure (cm water)</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="14.880221817899486" CI_START="-26.28022181789949" EFFECT_SIZE="-5.700000000000003" ESTIMABLE="YES" MEAN_1="100.7" MEAN_2="106.4" ORDER="57" SD_1="24.1" SD_2="29.9" SE="10.500306117986684" STUDY_ID="STD-Hasegawa-2000" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-007.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-05-10 16:05:38 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="33.53618139687021" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0" Z="0.0">
<NAME>Number of sphincter related complications</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.3803362702414206" CI_START="0.07999425355190828" EFFECT_SIZE="0.43636363636363634" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3766383141969447" LOG_CI_START="-1.0969412097622204" LOG_EFFECT_SIZE="-0.36015144778263786" ORDER="59" O_E="0.0" SE="0.8655879067098987" STUDY_ID="STD-Hasegawa-2000" TOTAL_1="14" TOTAL_2="13" VAR="0.7492424242424243" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.08" MODIFIED="2010-05-10 16:05:38 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="15.82123018695889" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="13" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Hospital stay (days)</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Defunctioning</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-4.740990290271747" CI_START="-10.859009709728252" EFFECT_SIZE="-7.799999999999999" ESTIMABLE="YES" MEAN_1="9.1" MEAN_2="16.9" ORDER="58" SD_1="4.0" SD_2="4.1" SE="1.5607479187665334" STUDY_ID="STD-Hasegawa-2000" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2013-06-06 14:06:29 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Overlap sphincter repair versus repair and biofeedback</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-008.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-07-08 11:57:08 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="223.15" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<DICH_DATA CI_END="68.23611392204987" CI_START="0.7368677500154261" EFFECT_SIZE="7.090909090909091" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.8340142855940096" LOG_CI_START="-0.132610450529499" LOG_EFFECT_SIZE="0.8507019175322553" ORDER="60" O_E="0.0" SE="1.155205104948396" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" VAR="1.3344988344988344" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="16" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-07-08 11:57:24 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="122.56" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Reapir only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<DICH_DATA CI_END="21.63760954220566" CI_START="0.07000740522900994" EFFECT_SIZE="1.2307692307692308" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="13" LOG_CI_END="1.3352092795411061" LOG_CI_START="-1.1548560188429302" LOG_EFFECT_SIZE="0.09017663034908803" ORDER="61" O_E="0.0" SE="1.4626766822928015" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" VAR="2.1394230769230766" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2010-07-08 11:58:01 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.04" MODIFIED="2010-07-08 11:44:00 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="8.471998172335429" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Continence grading scale score at 12 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.101355887007383" CI_START="-1.6013558870073852" EFFECT_SIZE="1.7499999999999991" ESTIMABLE="YES" MEAN_1="9.11" MEAN_2="7.36" ORDER="62" SD_1="4.9" SD_2="4.6" SE="1.7099068724948274" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.05" MODIFIED="2010-07-08 11:52:06 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.83" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Patient satisfaction score (VAS) at 12 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.491131954347598" CI_START="-0.3111319543475983" EFFECT_SIZE="1.5899999999999999" ESTIMABLE="YES" MEAN_1="-6.41" MEAN_2="-8.0" MODIFIED="2010-07-08 11:44:36 +0100" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="2.92" SD_2="2.48" SE="0.9699831064976113" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.06" MODIFIED="2010-07-08 11:50:01 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="3.14" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life score - lifestyle at 12 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2127656193519827" CI_START="0.30723438064801767" EFFECT_SIZE="0.7600000000000002" ESTIMABLE="YES" MEAN_1="-2.96" MEAN_2="-3.72" MODIFIED="2010-07-08 11:45:41 +0100" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="0.85" SD_2="0.39" SE="0.231007111826207" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.07" MODIFIED="2010-07-08 11:51:19 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.2" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life score - Coping at 12 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.2136391900395562" CI_START="-0.05363919003955686" EFFECT_SIZE="0.5799999999999996" ESTIMABLE="YES" MEAN_1="-2.43" MEAN_2="-3.01" MODIFIED="2010-07-08 11:51:19 +0100" MODIFIED_BY="[Empty name]" ORDER="65" SD_1="0.99" SD_2="0.81" SE="0.32329124159301986" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.08" MODIFIED="2010-07-08 11:53:27 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.99" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life score - (less) depression at 12 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.337887619827291" CI_START="0.1621123801727088" EFFECT_SIZE="0.75" ESTIMABLE="YES" MEAN_1="-2.75" MEAN_2="-3.5" MODIFIED="2010-07-08 11:53:05 +0100" MODIFIED_BY="[Empty name]" ORDER="66" SD_1="0.91" SD_2="0.76" SE="0.29994817479528896" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.09" MODIFIED="2010-07-08 11:54:54 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1.8870482054118094" SORT_BY="EFFECT_SIZE" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Quality of life score - embarrassment at 12 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.5387379474852674" CI_START="0.12126205251473277" EFFECT_SIZE="0.8300000000000001" ESTIMABLE="YES" MEAN_1="-2.46" MEAN_2="-3.29" MODIFIED="2010-07-08 11:54:50 +0100" MODIFIED_BY="[Empty name]" ORDER="67" SD_1="1.16" SD_2="0.85" SE="0.361607638240142" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.10" MODIFIED="2010-07-08 11:56:17 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="33.001989405845165" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Mean resting pressures (cm water) at 3 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="24.248356197217895" CI_START="-1.788356197217885" EFFECT_SIZE="11.230000000000004" ESTIMABLE="YES" MEAN_1="-57.5" MEAN_2="-68.73" MODIFIED="2010-07-08 11:55:46 +0100" MODIFIED_BY="[Empty name]" ORDER="68" SD_1="16.0" SD_2="20.17" SE="6.642140518859031" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.11" MODIFIED="2010-07-08 12:03:35 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="67.42741860899464" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="17" TOTAL_2="14" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Mean squeeze pressures (cm water) at 3 months</NAME>
<GROUP_LABEL_1>Repair only</GROUP_LABEL_1>
<GROUP_LABEL_2>Repair+biofeedback</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Repair only</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Biofeedback</GRAPH_LABEL_2>
<CONT_DATA CI_END="46.90242212924325" CI_START="-10.542422129243239" EFFECT_SIZE="18.180000000000007" ESTIMABLE="YES" MEAN_1="-102.0" MEAN_2="-120.18" MODIFIED="2010-07-08 12:03:31 +0100" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="32.8" SD_2="46.05" SE="14.654566285810375" STUDY_ID="STD-Davis-2004" TOTAL_1="17" TOTAL_2="14" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-009" MODIFIED="2013-06-06 14:06:20 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Total pelvic floor repair with internal sphincter plication versus total pelvic floor repair</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-009.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-23 07:30:24 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-009.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-23 07:30:42 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-009.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-07-23 07:30:49 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.04" MODIFIED="2010-05-10 16:09:02 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="4.173376197852419" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="18" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Incontinence score</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR/ISP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.37853497375814427" CI_START="-1.9985349737581444" EFFECT_SIZE="-0.81" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="3.61" ORDER="70" SD_1="1.66" SD_2="1.82" SE="0.6064065376369956" STUDY_ID="STD-Deen-1995" TOTAL_1="15" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.05" MODIFIED="2010-05-10 16:48:09 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="67.42741860899464" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="18" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum resting anal pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR/ISP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="41.005116175335985" CI_START="6.374883824664014" EFFECT_SIZE="23.689999999999998" ESTIMABLE="YES" MEAN_1="-63.2" MEAN_2="-86.89" ORDER="72" SD_1="18.5" SD_2="31.53" SE="8.834405280870165" STUDY_ID="STD-Deen-1995" TOTAL_1="15" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.06" MODIFIED="2010-05-10 16:48:10 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="16.540539784330416" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="18" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Improvement in mucosal electrosensitivity (mA)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR/ISP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="7.111589658965211" CI_START="-3.611589658965211" EFFECT_SIZE="1.7500000000000002" ESTIMABLE="YES" MEAN_1="2.22" MEAN_2="0.47" ORDER="73" SD_1="8.74" SD_2="6.56" SE="2.7355551945121164" STUDY_ID="STD-Deen-1995" TOTAL_1="15" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-009.07" MODIFIED="2010-05-10 16:48:11 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="73.33048868578125" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="18" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Rectal capacity (ml)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR/ISP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="52.32776403282567" CI_START="-15.927764032825692" EFFECT_SIZE="18.19999999999999" ESTIMABLE="YES" MEAN_1="-189.0" MEAN_2="-207.2" ORDER="74" SD_1="38.7" SD_2="60.5" SE="17.412444464296858" STUDY_ID="STD-Deen-1995" TOTAL_1="15" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-009.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 16:48:12 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="36.37524768419769" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in functional length of anal canal</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR/ISP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<DICH_DATA CI_END="14.072638912456675" CI_START="0.9455418634066401" EFFECT_SIZE="3.6477759279228046" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="1.1483755443186063" LOG_CI_START="-0.02431923821607205" LOG_EFFECT_SIZE="0.5620281530512672" ORDER="75" O_E="2.7272727272727275" SE="0.6888467201936644" STUDY_ID="STD-Deen-1995" TOTAL_1="15" TOTAL_2="18" VAR="2.1074380165289255" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-009.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 16:48:12 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with post-operative complications</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>TPFR/ISP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.206709557641933" CI_START="0.05677870948185021" EFFECT_SIZE="0.5936404288890492" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7928614230936829" LOG_CI_START="-1.2458144827379634" LOG_EFFECT_SIZE="-0.22647652982214023" ORDER="71" O_E="-0.36363636363636354" SE="1.1975283186939982" STUDY_ID="STD-Deen-1995" TOTAL_1="15" TOTAL_2="18" VAR="0.6973140495867768" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-010" MODIFIED="2013-06-06 14:06:11 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Gluteus maximus transposition (adynamic) versus total pelvic floor repair</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.01" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no change in incontinence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-010.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 16:10:09 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients failing to achieve full continence</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.586750373517825" CI_START="0.14103769475902922" EFFECT_SIZE="0.7112432807113478" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="5" LOG_CI_END="0.5547011522053217" LOG_CI_START="-0.8506647991319822" LOG_EFFECT_SIZE="-0.14798182346333028" ORDER="76" O_E="-0.5" SE="0.8255189164891872" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" VAR="1.467391304347826" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-010.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 16:10:24 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with no improvement in faecal urgency</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5673912672740244" CI_START="0.09251446093280918" EFFECT_SIZE="0.4873610767136191" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.4094920596606148" LOG_CI_START="-1.0337903773965391" LOG_EFFECT_SIZE="-0.31214915886796224" ORDER="77" O_E="-1.0" SE="0.8477912478906585" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" VAR="1.391304347826087" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.04" MODIFIED="2010-05-10 16:10:38 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="11.044521081175382" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Incontinence score</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.388844287189387" CI_START="-3.1888442871893856" EFFECT_SIZE="1.1000000000000005" ESTIMABLE="YES" MEAN_1="7.7" MEAN_2="6.6" ORDER="78" SD_1="6.1" SD_2="4.5" SE="2.18822606997845" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-010.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 16:10:50 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with post-operative complications</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<DICH_DATA CI_END="95.48480666496343" CI_START="0.8369300691679614" EFFECT_SIZE="8.939468991310237" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.9799342730863607" LOG_CI_START="-0.07731082855782875" LOG_EFFECT_SIZE="0.9513117222642661" ORDER="79" O_E="1.5" SE="1.2084359562332878" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" VAR="0.6847826086956521" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-010.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2010-05-10 16:10:58 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="6" TOTAL_2="7" WEIGHT="0.0" Z="0.0">
<NAME>Number of patients with adverse effects</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<DICH_DATA CI_END="19.803726058742267" CI_START="0.2960690360990208" EFFECT_SIZE="2.4214190230897428" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="1.2967469101862366" LOG_CI_START="-0.5286070102213017" LOG_EFFECT_SIZE="0.38406994998246746" ORDER="80" O_E="0.7692307692307692" SE="1.0722219284950192" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="6" TOTAL_2="7" VAR="0.8698224852071007" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.07" MODIFIED="2010-05-10 16:11:10 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="64.65116656253296" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum resting anal pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="23.571149063137767" CI_START="-17.371149063137764" EFFECT_SIZE="3.1000000000000014" ESTIMABLE="YES" MEAN_1="-60.3" MEAN_2="-63.4" ORDER="81" SD_1="16.5" SD_2="32.2" SE="10.44465573072341" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.08" MODIFIED="2010-05-10 16:11:23 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Mucosal electrosensitivity (mA)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.7810598539621445" CI_START="-6.581059853962142" EFFECT_SIZE="-1.8999999999999986" ESTIMABLE="YES" MEAN_1="10.8" MEAN_2="12.7" ORDER="82" SD_1="5.8" SD_2="5.9" SE="2.3883397301612406" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.09" MODIFIED="2010-05-10 16:11:31 +0100" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Maximum squeeze pressure (cm/water)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="33.78471665897224" CI_START="-30.184716658972246" EFFECT_SIZE="1.7999999999999972" ESTIMABLE="YES" MEAN_1="-92.7" MEAN_2="-94.5" ORDER="83" SD_1="25.8" SD_2="50.3" SE="16.319032855329795" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-010.10" MODIFIED="2010-05-10 16:11:44 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="2.204716903144654" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="12" TOTAL_2="12" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Length of high pressure zone (cm)</NAME>
<GROUP_LABEL_1/>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>GMT</GRAPH_LABEL_1>
<GRAPH_LABEL_2>TPFR</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.045103122693209596" CI_START="-1.2451031226932097" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" MEAN_1="-2.6" MEAN_2="-2.0" ORDER="84" SD_1="0.9" SD_2="0.7" SE="0.32914029430219166" STUDY_ID="STD-Yoshioka-1999" TOTAL_1="12" TOTAL_2="12" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-06-06 14:03:21 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-06-06 14:03:21 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>PRISMA study flow diagram.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-05-16 16:57:40 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2013-05-16 16:57:36 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES/>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;2 reports of 2 studies were included in the quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;9 reports of 9 studies were included in the qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;30 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;230 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;230 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;230 records identified through searching the Incontnence Group Specialised Register&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;200 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;21 reports of 19 studies, (full text articles) excluded, with reasons given in the &lt;a link_type=&quot;SECTION&quot; protected=&quot;true&quot; href=&quot;CHARACTERISTICS_OF_EXCLUDED_STUDIES&quot;&gt;Characteristics of excluded studies&lt;/a&gt; table&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>